Quiver News

$3,890,000 of LOCKHEED MARTIN CORPORATION lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"HR 1 - One Big Beautiful Bill Act, Title II, including issues related to aircraft, space programs, intelligence programs, missile programs, maritime programs, tax programs, Research Design Test and Evaluation (RDTE), procurement, munitions programs, rotary wing aviation, border protection programs; S (not yet introduced)/HR 4016 - Department of Defense Appropriations Act, 2026 including issues related to aircraft, space programs, intelligence programs, missile programs, maritime programs, RDTE, procurement, munition programs, helicopters, radars, sensors, directed energy programs; S (not yet introduced)/HR (not yet introduced) - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 including issues related to aircraft, space programs, acquisition; S (not yet introduced)/HR (not yet introduced) - Interior, Environment, and Related Agencies Subcommittee, 2026 including issues related to forest service technology HR 1 - One Big Beautiful Bill Act, Title II, including issues related to aircraft, spectrum, space programs, missiles, missile defense, technology development, intelligence programs, maritime programs, tax programs, defense funding; S (2296)/HR (3838) - National Defense Authorization Act for Fiscal Year 2026 including issues related to electromagnetic spectrum, acquisition policy, space programs, missiles, missile defense, technology development, aircraft, RDTE, procurement, munitions, helicopters, radars, sensors, directed energy programs; S (not yet introduced)/HR 4016 - Department of Defense Appropriations Act, 2026 including issues related to aircraft, space programs, missiles, missile defense, technology development, maritime programs, intelligence programs, helicopters; S 5618 - FoRGED Act including issues related to acquisition policy HR 1 - One Big Beautiful Bill Act including issues related to aircraft, space programs, intelligence programs, missile programs, maritime programs, tax programs; S (not yet introduced)/HR (not yet introduced) - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 including issues related aircraft, space programs, acquisition; S (not yet introduced)/HR 4016 - Department of Defense Appropriations Act, 2026 including issues related to aircraft, space programs, intelligence programs, missile programs, maritime programs S (not yet introduced)/HR (not yet introduced) - Interior, Environment, and Related Agencies Subcommittee, 2026 including issues related to wildfire technology, firefighting intelligence HR 1 - One Big Beautiful Bill Act including issues related research and development, foreign-derived intangible income, health savings account issues, healthcare taxation; S 1639/HR 1990 - American Innovation and Jobs Act including issues related to research and development amortization HR 3613 - Streamlining Foreign Military Sales Act of 2025 including issues related to foreign military sales reform S (not yet introduced)/HR (not yet introduced) - Intelligence Authorization Act for 2026 including issues related to classified intelligence matters"

You can find more data on corporate lobbying on Quiver Quantitative.

LMT Congressional Stock Trading

Members of Congress have traded $LMT stock 8 times in the past 6 months. Of those trades, 4 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $LMT stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 08/05, 04/29 and 1 sale worth up to $15,000 on 05/30.
• REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 04/11 and 1 sale worth up to $50,000 on 05/12.
• REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 04/07.
• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.
• REPRESENTATIVE GEORGE WHITESIDES sold up to $100,000 on 03/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

LMT Hedge Fund Activity

We have seen 1,223 institutional investors add shares of LMT stock to their portfolio, and 1,257 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GAMMA INVESTING LLC removed 1,985,876 shares (-99.7%) from their portfolio in Q2 2025, for an estimated $919,738,610
• TABLEAUX LLC added 621,300 shares (+34231.4%) to their portfolio in Q2 2025, for an estimated $287,748,882
• DEMARS FINANCIAL GROUP, LLC removed 392,478 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $181,772,260
• FIRST TRUST ADVISORS LP removed 382,969 shares (-74.6%) from their portfolio in Q2 2025, for an estimated $177,368,262
• MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. added 359,748 shares (+169.3%) to their portfolio in Q2 2025, for an estimated $166,613,688
• BLACKROCK, INC. added 352,765 shares (+2.1%) to their portfolio in Q2 2025, for an estimated $163,379,582
• MORGAN STANLEY added 330,891 shares (+6.6%) to their portfolio in Q2 2025, for an estimated $153,248,857

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

LMT Analyst Ratings

Wall Street analysts have issued reports on $LMT in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Baird issued a "Outperform" rating on 07/23/2025
• Susquehanna issued a "Positive" rating on 07/23/2025
• Truist Securities issued a "Buy" rating on 07/11/2025

To track analyst ratings and price targets for LMT, check out Quiver Quantitative's $LMT forecast page.

LMT Price Targets

Multiple analysts have issued price targets for $LMT recently. We have seen 9 analysts offer price targets for $LMT in the last 6 months, with a median target of $465.0.

Here are some recent targets:

• Ronald Epstein from B of A Securities set a target price of $480.0 on 08/21/2025
• Peter Arment from Baird set a target price of $500.0 on 07/23/2025
• Seth Seifman from JP Morgan set a target price of $465.0 on 07/23/2025
• Michael Ciarmoli from Truist Securities set a target price of $440.0 on 07/23/2025
• Gavin Parsons from UBS set a target price of $453.0 on 07/23/2025
• Ken Herbert from RBC Capital set a target price of $440.0 on 07/23/2025
• Charles Minervino from Susquehanna set a target price of $490.0 on 07/23/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$900,000 of CORTEVA AGRISCIENCE LLC (FKA E I DU PONT DE NEMOURS AND COMPANY) lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Implementation and oversight of the Agriculture Marketing Act of 1946 to require the Secretary of Proposed update to plant incorporated protectant rule and proposed update to guidance clarifying the regulatory approach for food from plantsdeveloped with the newest tools of genome editing. 7CFR Part 340 Pesticide Matters Seed Matters Climate change matters 2024 Farm Bill Endangered Species Act and Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Biostimulant regulatory matters Pesticide matters Farm Bill 2024 Endangered Species Act and Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Pesticide matters Climate change matters Trade Intellectual property rights and protection Agriculture trade Trade and international relations Tariff matters Seed trade matters Issues related to Mexico's regulation of agricultural biotechnology and pesticides Corporate taxation matters Taxation matters impacting US farmers 2025 NDAA Intellectual property rights and protection Technology access"

You can find more data on corporate lobbying on Quiver Quantitative.

CTVA Insider Trading Activity

CTVA insiders have traded $CTVA stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CTVA stock by insiders over the last 6 months:

• CORNEL B FUERER (See Remarks) sold 55,242 shares for an estimated $3,759,770
• ROBERT D. KING (EVP, Crop Protection Business) sold 37,280 shares for an estimated $2,765,993

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CTVA Hedge Fund Activity

We have seen 657 institutional investors add shares of CTVA stock to their portfolio, and 624 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• HARRIS ASSOCIATES L P removed 6,043,980 shares (-46.7%) from their portfolio in Q2 2025, for an estimated $450,457,829
• MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 5,332,353 shares (-43.2%) from their portfolio in Q2 2025, for an estimated $397,420,269
• FMR LLC added 4,777,344 shares (+52.8%) to their portfolio in Q2 2025, for an estimated $356,055,448
• CAPITAL WORLD INVESTORS added 3,934,636 shares (+20.4%) to their portfolio in Q2 2025, for an estimated $293,248,421
• VAN ECK ASSOCIATES CORP removed 3,775,701 shares (-43.9%) from their portfolio in Q2 2025, for an estimated $281,402,995
• INDEPENDENT FRANCHISE PARTNERS LLP removed 3,389,825 shares (-20.2%) from their portfolio in Q2 2025, for an estimated $252,643,657
• VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. removed 2,731,022 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $171,863,214

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CTVA Analyst Ratings

Wall Street analysts have issued reports on $CTVA in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Wells Fargo issued a "Overweight" rating on 08/08/2025
• Keybanc issued a "Overweight" rating on 08/08/2025
• UBS issued a "Buy" rating on 08/07/2025
• BMO Capital issued a "Outperform" rating on 07/08/2025
• Jefferies issued a "Buy" rating on 06/06/2025
• Citigroup issued a "Buy" rating on 05/09/2025
• Morgan Stanley issued a "Overweight" rating on 05/09/2025

To track analyst ratings and price targets for CTVA, check out Quiver Quantitative's $CTVA forecast page.

CTVA Price Targets

Multiple analysts have issued price targets for $CTVA recently. We have seen 12 analysts offer price targets for $CTVA in the last 6 months, with a median target of $84.5.

Here are some recent targets:

• Benjamin Theurer from Barclays set a target price of $84.0 on 08/13/2025
• Richard Garchitorena from Wells Fargo set a target price of $83.0 on 08/08/2025
• Aleksey Yefremov from Keybanc set a target price of $85.0 on 08/08/2025
• Joshua Spector from UBS set a target price of $91.0 on 08/07/2025
• Kristen Owen from Oppenheimer set a target price of $87.0 on 07/15/2025
• Arun Viswanathan from RBC Capital set a target price of $85.0 on 07/10/2025
• Joel Jackson from BMO Capital set a target price of $86.0 on 07/08/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$40,000 of ANHEUSER-BUSCH COMPANIES lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"IP infringement and rule-of-law issues in Mexico."

You can find more data on corporate lobbying on Quiver Quantitative.

BUD Congressional Stock Trading

Members of Congress have traded $BUD stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $BUD stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 2 purchases worth up to $30,000 on 07/16, 06/09 and 2 sales worth up to $30,000 on 08/04, 06/11.
• REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

BUD Hedge Fund Activity

We have seen 246 institutional investors add shares of BUD stock to their portfolio, and 282 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC added 5,405,244 shares (+348.6%) to their portfolio in Q2 2025, for an estimated $371,448,367
• DODGE & COX removed 2,638,596 shares (-6.4%) from their portfolio in Q2 2025, for an estimated $181,324,317
• ROYAL BANK OF CANADA removed 1,920,047 shares (-48.6%) from their portfolio in Q2 2025, for an estimated $131,945,629
• HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 1,559,800 shares (-55.9%) from their portfolio in Q2 2025, for an estimated $107,189,456
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 1,361,743 shares (-74.9%) from their portfolio in Q2 2025, for an estimated $93,578,978
• ARMISTICE CAPITAL, LLC removed 1,359,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $83,660,040
• RIVULET CAPITAL, LLC removed 1,115,250 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $68,654,790

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BUD Analyst Ratings

Wall Street analysts have issued reports on $BUD in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Goldman Sachs issued a "Buy" rating on 05/12/2025

To track analyst ratings and price targets for BUD, check out Quiver Quantitative's $BUD forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$825,887 of FLUOR CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to ongoing transportation projects. Issues related to Implementation of the Infrastructure Investment and Jobs Act, P.L. 117-58. Issues related to authorization of Surface Transportation Act. Issues related to ongoing management of DOE projects. Issues related to construction of commercial energy operations, as well as DOE grant and loan guarantee programs. Issues related to domestic & international energy projects. Issues related to SMR development. Issues related to funding of DOD, DOE, DOT and DHS programs in the Continuing Appropriations and Extensions Act, 2025 --HR 1968. P.L. 119-4. Issues related to FY26 Energy and Water Appropriations. Issues related to DOD contingency operations and support services--FY 2026 National Defense Authorization Act (NDAA). Monitored issues related to LOGCAP and AFCAP. Issues related to AUKUS and associated projects in Australia. CHIPS projects related to funding and policy--Building Chips in America Act--S2228, P.L. 118-105. Issues related to overseas projects and operations. Issues related to management of FEMA Operations, Disaster Recovery, and declarations. Issues related to global emissions reporting standards."

You can find more data on corporate lobbying on Quiver Quantitative.

FLR Insider Trading Activity

FLR insiders have traded $FLR stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $FLR stock by insiders over the last 6 months:

• DAVID E CONSTABLE (Executive Chairman) has made 0 purchases and 3 sales selling 119,400 shares for an estimated $6,016,946.
• ALVIN C III COLLINS (GROUP PRESIDENT) has made 0 purchases and 2 sales selling 21,908 shares for an estimated $1,015,304.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

FLR Hedge Fund Activity

We have seen 267 institutional investors add shares of FLR stock to their portfolio, and 296 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• RUBRIC CAPITAL MANAGEMENT LP added 4,000,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $205,080,000
• DME CAPITAL MANAGEMENT, LP added 3,819,580 shares (+inf%) to their portfolio in Q2 2025, for an estimated $195,829,866
• ENCOMPASS CAPITAL ADVISORS LLC added 2,091,170 shares (+inf%) to their portfolio in Q2 2025, for an estimated $107,214,285
• SOURCEROCK GROUP LLC added 1,664,266 shares (+inf%) to their portfolio in Q2 2025, for an estimated $85,326,917
• MILLENNIUM MANAGEMENT LLC removed 1,315,765 shares (-41.0%) from their portfolio in Q2 2025, for an estimated $67,459,271
• TROLUCE CAPITAL ADVISORS LLC added 1,300,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $66,651,000
• SQUAREPOINT OPS LLC removed 1,202,623 shares (-78.8%) from their portfolio in Q2 2025, for an estimated $61,658,481

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

FLR Analyst Ratings

Wall Street analysts have issued reports on $FLR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• UBS issued a "Buy" rating on 08/06/2025
• Citigroup issued a "Buy" rating on 08/04/2025
• Truist Securities issued a "Buy" rating on 07/03/2025

To track analyst ratings and price targets for FLR, check out Quiver Quantitative's $FLR forecast page.

FLR Price Targets

Multiple analysts have issued price targets for $FLR recently. We have seen 5 analysts offer price targets for $FLR in the last 6 months, with a median target of $56.0.

Here are some recent targets:

• Steven Fisher from UBS set a target price of $56.0 on 08/06/2025
• Andrew Kaplowitz from Citigroup set a target price of $57.0 on 08/04/2025
• Andrew Wittmann from Baird set a target price of $46.0 on 08/04/2025
• Sangita Jain from Keybanc set a target price of $41.0 on 07/16/2025
• Jamie Cook from Truist Securities set a target price of $59.0 on 07/03/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$620,000 of ARDELYX INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Medicare, ESRD Bundle, H.R.5074, S.4510, Kidney Patient Act"

You can find more data on corporate lobbying on Quiver Quantitative.

ARDX Insider Trading Activity

ARDX insiders have traded $ARDX stock on the open market 20 times in the past 6 months. Of those trades, 4 have been purchases and 16 have been sales.

Here’s a breakdown of recent trading of $ARDX stock by insiders over the last 6 months:

• DAVID M MOTT has made 4 purchases buying 881,377 shares for an estimated $3,403,196 and 0 sales.
• MICHAEL RAAB (President & CEO) has made 0 purchases and 4 sales selling 175,836 shares for an estimated $830,399.
• LAURA A WILLIAMS (Chief Patient Officer) has made 0 purchases and 4 sales selling 92,682 shares for an estimated $553,025.
• ERIC DUANE FOSTER (Chief Commercial Officer) has made 0 purchases and 2 sales selling 17,815 shares for an estimated $101,034.
• MIKE KELLIHER (Chief Business Officer) has made 0 purchases and 2 sales selling 19,939 shares for an estimated $91,402.
• JUSTIN A RENZ (Chief Financial Officer) has made 0 purchases and 2 sales selling 14,255 shares for an estimated $71,200.
• ELIZABETH A GRAMMER (See Remarks) has made 0 purchases and 2 sales selling 11,833 shares for an estimated $59,102.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ARDX Hedge Fund Activity

We have seen 107 institutional investors add shares of ARDX stock to their portfolio, and 131 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JANUS HENDERSON GROUP PLC removed 9,919,066 shares (-39.7%) from their portfolio in Q2 2025, for an estimated $38,882,738
• EVENTIDE ASSET MANAGEMENT, LLC removed 5,600,764 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $27,499,751
• MILLENNIUM MANAGEMENT LLC added 5,197,967 shares (+80.4%) to their portfolio in Q2 2025, for an estimated $20,376,030
• MARSHALL WACE, LLP added 2,866,843 shares (+34.2%) to their portfolio in Q2 2025, for an estimated $11,238,024
• BLACKROCK, INC. added 2,799,200 shares (+15.6%) to their portfolio in Q2 2025, for an estimated $10,972,864
• BANK OF AMERICA CORP /DE/ added 2,600,080 shares (+88.8%) to their portfolio in Q2 2025, for an estimated $10,192,313
• JONES FINANCIAL COMPANIES LLLP added 1,832,320 shares (+16861.3%) to their portfolio in Q2 2025, for an estimated $7,182,694

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ARDX Analyst Ratings

Wall Street analysts have issued reports on $ARDX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• HC Wainwright & Co. issued a "Buy" rating on 06/18/2025
• Citigroup issued a "Buy" rating on 05/02/2025

To track analyst ratings and price targets for ARDX, check out Quiver Quantitative's $ARDX forecast page.

ARDX Price Targets

Multiple analysts have issued price targets for $ARDX recently. We have seen 5 analysts offer price targets for $ARDX in the last 6 months, with a median target of $10.0.

Here are some recent targets:

• Christopher Raymond from Piper Sandler set a target price of $9.0 on 08/06/2025
• Laura Chico from Wedbush set a target price of $14.0 on 08/05/2025
• Ryan Deschner from Raymond James set a target price of $12.0 on 08/05/2025
• Matthew Caufield from HC Wainwright & Co. set a target price of $10.0 on 06/18/2025
• Yigal Nochomovitz from Citigroup set a target price of $10.0 on 05/02/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$130,000 of AEROVIRONMENT INC. lobbying was just disclosed, from Q3 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"FY25 Defense Authorization and Appropriations."

You can find more data on corporate lobbying on Quiver Quantitative.

AVAV Insider Trading Activity

AVAV insiders have traded $AVAV stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $AVAV stock by insiders over the last 6 months:

• WAHID NAWABI (Chair, President and CEO) has made 0 purchases and 2 sales selling 46,666 shares for an estimated $8,315,486.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AVAV Hedge Fund Activity

We have seen 294 institutional investors add shares of AVAV stock to their portfolio, and 217 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VANGUARD GROUP INC added 433,830 shares (+14.3%) to their portfolio in Q2 2025, for an estimated $123,619,858
• ALYESKA INVESTMENT GROUP, L.P. removed 415,203 shares (-46.0%) from their portfolio in Q2 2025, for an estimated $118,312,094
• POINT72 ASSET MANAGEMENT, L.P. removed 383,659 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $109,323,632
• DRIEHAUS CAPITAL MANAGEMENT LLC added 293,860 shares (+inf%) to their portfolio in Q2 2025, for an estimated $83,735,407
• HEARD CAPITAL LLC removed 286,347 shares (-34.1%) from their portfolio in Q2 2025, for an estimated $81,594,577
• INVESCO LTD. added 262,239 shares (+75.6%) to their portfolio in Q2 2025, for an estimated $74,725,003
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 258,934 shares (+inf%) to their portfolio in Q2 2025, for an estimated $73,783,243

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AVAV Analyst Ratings

Wall Street analysts have issued reports on $AVAV in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• BTIG issued a "Buy" rating on 09/11/2025
• Needham issued a "Buy" rating on 09/10/2025
• JMP Securities issued a "Market Outperform" rating on 08/18/2025
• Canaccord Genuity issued a "Buy" rating on 08/11/2025
• Baird issued a "Outperform" rating on 08/04/2025
• RBC Capital issued a "Outperform" rating on 07/17/2025
• Jefferies issued a "Buy" rating on 07/02/2025

To track analyst ratings and price targets for AVAV, check out Quiver Quantitative's $AVAV forecast page.

AVAV Price Targets

Multiple analysts have issued price targets for $AVAV recently. We have seen 12 analysts offer price targets for $AVAV in the last 6 months, with a median target of $300.0.

Here are some recent targets:

• Andre Madrid from BTIG set a target price of $300.0 on 09/11/2025
• Austin Bohlig from Needham set a target price of $300.0 on 09/10/2025
• Trevor Walsh from JMP Securities set a target price of $325.0 on 08/18/2025
• Austin Moeller from Canaccord Genuity set a target price of $305.0 on 08/11/2025
• Peter Arment from Baird set a target price of $267.0 on 08/04/2025
• Kevin Liu from RBC Capital set a target price of $300.0 on 07/17/2025
• Colin Canfield from Cantor Fitzgerald set a target price of $335.0 on 07/08/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$60,000 of KILROY REALTY lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"VISN 21 VA facilities modernization Marine Corps Air Station Miramar flight regulations Corporate State and Local Tax Deduction"

You can find more data on corporate lobbying on Quiver Quantitative.

KRC Hedge Fund Activity

We have seen 174 institutional investors add shares of KRC stock to their portfolio, and 208 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• COHEN & STEERS, INC. added 10,249,689 shares (+158.7%) to their portfolio in Q2 2025, for an estimated $351,666,829
• DAIWA SECURITIES GROUP INC. added 2,236,539 shares (+168.6%) to their portfolio in Q2 2025, for an estimated $76,735,653
• FMR LLC removed 1,502,396 shares (-25.6%) from their portfolio in Q2 2025, for an estimated $51,547,206
• BLACKROCK, INC. added 1,148,713 shares (+7.8%) to their portfolio in Q2 2025, for an estimated $39,412,343
• CANADA PENSION PLAN INVESTMENT BOARD removed 1,035,000 shares (-26.7%) from their portfolio in Q2 2025, for an estimated $35,510,850
• ROUTE ONE INVESTMENT COMPANY, L.P. added 1,000,900 shares (+inf%) to their portfolio in Q2 2025, for an estimated $34,340,879
• SCHRODER INVESTMENT MANAGEMENT GROUP removed 993,096 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $34,073,123

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

KRC Analyst Ratings

Wall Street analysts have issued reports on $KRC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Scotiabank issued a "Sector Underperform" rating on 08/28/2025
• Goldman Sachs issued a "Sell" rating on 08/21/2025
• JP Morgan issued a "Overweight" rating on 07/02/2025
• Keybanc issued a "Overweight" rating on 03/31/2025

To track analyst ratings and price targets for KRC, check out Quiver Quantitative's $KRC forecast page.

KRC Price Targets

Multiple analysts have issued price targets for $KRC recently. We have seen 10 analysts offer price targets for $KRC in the last 6 months, with a median target of $40.0.

Here are some recent targets:

• Steve Sakwa from Evercore ISI Group set a target price of $46.0 on 09/08/2025
• Brendan Lynch from Barclays set a target price of $43.0 on 09/04/2025
• Nicholas Yulico from Scotiabank set a target price of $40.0 on 08/28/2025
• Blaine Heck from Wells Fargo set a target price of $40.0 on 08/27/2025
• Caitlin Burrows from Goldman Sachs set a target price of $33.0 on 08/21/2025
• Michael Carroll from RBC Capital set a target price of $40.0 on 08/07/2025
• John Kim from BMO Capital set a target price of $35.0 on 07/16/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$650,000 of BOOZ ALLEN HAMILTON INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"- H.R. 3838 / S. 2296 FY26 National Defense Authorization Act, all provisions related to Cybersecurity, Acquisition, and Missile Defense. - Emerging Technologies - Intelligence Authorization Act, 2026, all provisions related to: Cybersecurity - Cybersecurity - IRS Modernization - FAA Modernization - Artificial Intelligence - Quantum - Cyber - H.R. 4016/ S. ## FY26 Defense Appropriations, all provisions related to Missile Defense - H.R. 1 Reconciliation Bill, all provisions related to Missile Defense - Issues related to Health IT Modernization"

You can find more data on corporate lobbying on Quiver Quantitative.

BAH Hedge Fund Activity

We have seen 346 institutional investors add shares of BAH stock to their portfolio, and 479 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 2,296,316 shares (+inf%) to their portfolio in Q2 2025, for an estimated $239,115,385
• PRICE T ROWE ASSOCIATES INC /MD/ removed 1,447,160 shares (-20.5%) from their portfolio in Q2 2025, for an estimated $150,692,770
• PRIMECAP MANAGEMENT CO/CA/ added 1,207,058 shares (+2011.8%) to their portfolio in Q2 2025, for an estimated $125,690,949
• JPMORGAN CHASE & CO removed 1,120,283 shares (-45.0%) from their portfolio in Q2 2025, for an estimated $116,655,068
• JANUS HENDERSON GROUP PLC removed 1,081,675 shares (-44.5%) from their portfolio in Q2 2025, for an estimated $112,634,817
• MAN GROUP PLC removed 1,067,599 shares (-74.5%) from their portfolio in Q2 2025, for an estimated $111,169,083
• TWO SIGMA INVESTMENTS, LP removed 1,044,793 shares (-88.1%) from their portfolio in Q2 2025, for an estimated $108,794,295

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BAH Analyst Ratings

Wall Street analysts have issued reports on $BAH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• JP Morgan issued a "Underweight" rating on 07/28/2025
• William Blair issued a "Outperform" rating on 07/22/2025
• Goldman Sachs issued a "Sell" rating on 05/28/2025
• Wells Fargo issued a "Overweight" rating on 05/27/2025

To track analyst ratings and price targets for BAH, check out Quiver Quantitative's $BAH forecast page.

BAH Price Targets

Multiple analysts have issued price targets for $BAH recently. We have seen 7 analysts offer price targets for $BAH in the last 6 months, with a median target of $119.0.

Here are some recent targets:

• Jonathan Siegmann from Stifel set a target price of $119.0 on 07/28/2025
• Seth Seifman from JP Morgan set a target price of $122.0 on 07/28/2025
• Gavin Parsons from UBS set a target price of $119.0 on 07/28/2025
• Noah Poponak from Goldman Sachs set a target price of $94.0 on 05/28/2025
• David Strauss from Barclays set a target price of $120.0 on 05/28/2025
• Matthew Akers from Wells Fargo set a target price of $135.0 on 05/27/2025
• Tobey Sommer from Truist Securities set a target price of $110.0 on 04/14/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$557,000 of BECTON DICKINSON AND COMPANY lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health Issues related to corporate taxation Tax incentives for domestic manufacturing Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization Issues related to medical device supply chain"

You can find more data on corporate lobbying on Quiver Quantitative.

BDX Congressional Stock Trading

Members of Congress have traded $BDX stock 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $BDX stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/17 and 1 sale worth up to $15,000 on 06/24.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 05/15 and 1 sale worth up to $15,000 on 04/08.
• REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 05/13.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

BDX Insider Trading Activity

BDX insiders have traded $BDX stock on the open market 9 times in the past 6 months. Of those trades, 1 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:

• GREGORY HAYES purchased 5,250 shares for an estimated $1,005,742
• CLAIRE FRASER has made 0 purchases and 2 sales selling 1,780 shares for an estimated $337,892.
• MICHAEL DAVID GARRISON (EVP & President, Medical) has made 0 purchases and 3 sales selling 1,664 shares for an estimated $308,141.
• DAVID SHAN (EVP and Chief ISC Officer) sold 1,166 shares for an estimated $199,607
• RICHARD BYRD (EVP & President Interventional) sold 459 shares for an estimated $105,570
• MICHAEL FELD (EVP & President, Life Sciences) sold 57 shares for an estimated $11,285

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BDX Hedge Fund Activity

We have seen 702 institutional investors add shares of BDX stock to their portfolio, and 926 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MORGAN STANLEY removed 4,598,284 shares (-53.5%) from their portfolio in Q2 2025, for an estimated $792,054,419
• VANGUARD GROUP INC added 4,305,947 shares (+15.4%) to their portfolio in Q2 2025, for an estimated $741,699,370
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 3,603,168 shares (+28.7%) to their portfolio in Q2 2025, for an estimated $620,645,688
• BLACKROCK, INC. added 3,389,963 shares (+14.2%) to their portfolio in Q2 2025, for an estimated $583,921,126
• FIRST EAGLE INVESTMENT MANAGEMENT, LLC added 3,268,478 shares (+59.2%) to their portfolio in Q2 2025, for an estimated $562,995,335
• GQG PARTNERS LLC removed 3,011,583 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $518,745,171
• GENERATION INVESTMENT MANAGEMENT LLP removed 2,537,140 shares (-47.9%) from their portfolio in Q2 2025, for an estimated $437,022,365

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BDX Analyst Ratings

Wall Street analysts have issued reports on $BDX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Overweight" rating on 06/03/2025
• Morgan Stanley issued a "Overweight" rating on 05/06/2025
• Stifel issued a "Buy" rating on 05/02/2025

To track analyst ratings and price targets for BDX, check out Quiver Quantitative's $BDX forecast page.

BDX Price Targets

Multiple analysts have issued price targets for $BDX recently. We have seen 7 analysts offer price targets for $BDX in the last 6 months, with a median target of $200.0.

Here are some recent targets:

• Patrick Wood from Morgan Stanley set a target price of $197.0 on 08/11/2025
• Jason Bednar from Piper Sandler set a target price of $200.0 on 08/08/2025
• Lawrence Biegelsen from Wells Fargo set a target price of $184.0 on 08/08/2025
• Matt Miksic from Barclays set a target price of $241.0 on 06/03/2025
• Joanna Wiensch from Citigroup set a target price of $185.0 on 05/22/2025
• Rick Wise from Stifel set a target price of $224.0 on 05/02/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$130,000 of HORMEL FOODS CORPORATION lobbying was just disclosed, from Q2 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"CO2 supply, NSIS and line speed parameters, Animal disease prevention Worker visa programs for agriculture and food processing workers Worker visas for agriculture and food processing Food Labeling safety, Nutritional standards, dietary guidelines, Front of Pack labeling Increased market access for Food and Agriculture Products worldwide and in countries such as China, Japan, Mexico, EU, Canada and England. Steel tinplate tariffs. Maintain and do not increase the the federal corporate tax rate Identify avenues to minimize or eliminate tariffs on necessary packaging materials. Steel tinplate tariffs."

You can find more data on corporate lobbying on Quiver Quantitative.

HRL Congressional Stock Trading

Members of Congress have traded $HRL stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $HRL stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/16 and 1 sale worth up to $15,000 on 07/22.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

HRL Insider Trading Activity

HRL insiders have traded $HRL stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $HRL stock by insiders over the last 6 months:

• ELSA A MURANO sold 4,500 shares for an estimated $136,800

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

HRL Hedge Fund Activity

We have seen 320 institutional investors add shares of HRL stock to their portfolio, and 364 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CITADEL ADVISORS LLC added 3,476,309 shares (+115.9%) to their portfolio in Q2 2025, for an estimated $105,158,347
• STIFEL FINANCIAL CORP removed 3,383,050 shares (-65.5%) from their portfolio in Q2 2025, for an estimated $102,337,262
• PACER ADVISORS, INC. removed 2,303,912 shares (-98.6%) from their portfolio in Q2 2025, for an estimated $69,693,338
• D. E. SHAW & CO., INC. removed 1,238,687 shares (-76.1%) from their portfolio in Q2 2025, for an estimated $37,470,281
• J. GOLDMAN & CO LP added 1,078,328 shares (+inf%) to their portfolio in Q2 2025, for an estimated $32,619,422
• SQUAREPOINT OPS LLC removed 1,056,614 shares (-98.9%) from their portfolio in Q2 2025, for an estimated $31,962,573
• UBS GROUP AG added 964,466 shares (+32.2%) to their portfolio in Q2 2025, for an estimated $29,175,096

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

HRL Analyst Ratings

Wall Street analysts have issued reports on $HRL in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Goldman Sachs issued a "Buy" rating on 08/29/2025
• Barclays issued a "Overweight" rating on 08/29/2025
• JP Morgan issued a "Overweight" rating on 08/29/2025

To track analyst ratings and price targets for HRL, check out Quiver Quantitative's $HRL forecast page.

HRL Price Targets

Multiple analysts have issued price targets for $HRL recently. We have seen 6 analysts offer price targets for $HRL in the last 6 months, with a median target of $31.0.

Here are some recent targets:

• Adam Samuelson from Goldman Sachs set a target price of $31.0 on 08/29/2025
• Peter Galbo from B of A Securities set a target price of $28.0 on 08/29/2025
• Benjamin Theurer from Barclays set a target price of $34.0 on 08/29/2025
• Thomas Palmer from JP Morgan set a target price of $30.0 on 08/29/2025
• Pooran Sharma from Stephens & Co. set a target price of $31.0 on 05/22/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$60,000 of TIMKEN COMPANY lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Fiscal year appropriations Environmental Issues Defense Issues Immigration Issues Labor/Workforce Issues Tax Issues Trade Issues"

You can find more data on corporate lobbying on Quiver Quantitative.

TKR Congressional Stock Trading

Members of Congress have traded $TKR stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $TKR stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/11 and 1 sale worth up to $15,000 on 06/17.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

TKR Insider Trading Activity

TKR insiders have traded $TKR stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $TKR stock by insiders over the last 6 months:

• HANSAL N. PATEL (EVP, GC and Secretary) sold 4,869 shares for an estimated $385,381

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

TKR Hedge Fund Activity

We have seen 211 institutional investors add shares of TKR stock to their portfolio, and 257 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• THRIVENT FINANCIAL FOR LUTHERANS removed 1,506,967 shares (-97.9%) from their portfolio in Q2 2025, for an estimated $109,330,455
• COOKE & BIELER LP added 855,961 shares (+341.0%) to their portfolio in Q2 2025, for an estimated $62,099,970
• FMR LLC removed 815,427 shares (-18.7%) from their portfolio in Q2 2025, for an estimated $59,159,228
• FULLER & THALER ASSET MANAGEMENT, INC. added 647,917 shares (+47.0%) to their portfolio in Q2 2025, for an estimated $47,006,378
• ROYAL LONDON ASSET MANAGEMENT LTD removed 485,318 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $34,879,804
• AMERICAN CENTURY COMPANIES INC added 455,050 shares (+13.4%) to their portfolio in Q2 2025, for an estimated $33,013,877
• INVESCO LTD. added 427,879 shares (+241.7%) to their portfolio in Q2 2025, for an estimated $31,042,621

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TKR Analyst Ratings

Wall Street analysts have issued reports on $TKR in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Citigroup issued a "Buy" rating on 06/24/2025
• Evercore ISI Group issued a "Outperform" rating on 05/19/2025
• Oppenheimer issued a "Outperform" rating on 05/01/2025
• Morgan Stanley issued a "Overweight" rating on 04/16/2025

To track analyst ratings and price targets for TKR, check out Quiver Quantitative's $TKR forecast page.

TKR Price Targets

Multiple analysts have issued price targets for $TKR recently. We have seen 8 analysts offer price targets for $TKR in the last 6 months, with a median target of $80.0.

Here are some recent targets:

• Michael Shlisky from DA Davidson set a target price of $80.0 on 07/22/2025
• Kyle Menges from Citigroup set a target price of $80.0 on 06/24/2025
• David Raso from Evercore ISI Group set a target price of $85.0 on 05/19/2025
• Bryan Blair from Oppenheimer set a target price of $88.0 on 05/01/2025
• Chris Dankert from Loop Capital set a target price of $65.0 on 04/17/2025
• Angel Castillo from Morgan Stanley set a target price of $88.0 on 04/16/2025
• Joe Ritchie from Goldman Sachs set a target price of $75.0 on 04/02/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$50,000 of OCEANEERING INTERNATIONAL INC lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Provided Personal and Professional Staff members with an update to the programs that Oceaneering supports with NASA and commercial space entities Provided Personal and Professional Staff Members with an update on programs that Oceaneering currently supports for the Department of Defense Provided Personal and Professional Staff members with an update on the Energy Programs that Oceaneering is involved in. Provided Personal and Professional Staff Members with information about Oceaneering's transportation and warehousing projects and programs"

You can find more data on corporate lobbying on Quiver Quantitative.

OII Insider Trading Activity

OII insiders have traded $OII stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $OII stock by insiders over the last 6 months:

• ALAN R CURTIS (SVP and CFO) sold 14,840 shares for an estimated $361,474
• KAREN H BEACHY sold 5,300 shares for an estimated $100,382

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

OII Hedge Fund Activity

We have seen 158 institutional investors add shares of OII stock to their portfolio, and 169 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CONGRESS ASSET MANAGEMENT CO removed 1,790,545 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $37,100,092
• BALYASNY ASSET MANAGEMENT L.P. added 1,227,950 shares (+916.6%) to their portfolio in Q2 2025, for an estimated $25,443,124
• BLACKROCK, INC. removed 879,127 shares (-5.3%) from their portfolio in Q2 2025, for an estimated $18,215,511
• BROWN ADVISORY INC added 799,718 shares (+12.2%) to their portfolio in Q2 2025, for an estimated $16,570,156
• FIL LTD removed 796,575 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $16,505,034
• FMR LLC removed 668,636 shares (-70.1%) from their portfolio in Q2 2025, for an estimated $13,854,137
• MILLENNIUM MANAGEMENT LLC added 630,543 shares (+619.2%) to their portfolio in Q2 2025, for an estimated $13,064,850

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$40,000 of OSHKOSH CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"US manufacturing and international competitiveness US manufacturing and international competitiveness US manufacturing and international competitiveness"

You can find more data on corporate lobbying on Quiver Quantitative.

OSK Insider Trading Activity

OSK insiders have traded $OSK stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $OSK stock by insiders over the last 6 months:

• IGNACIO A CORTINA (EVP, CL&AO & Secretary) has made 0 purchases and 2 sales selling 12,725 shares for an estimated $1,764,109.
• JAMES C FREEDERS (SVP, Finance and Controller) has made 0 purchases and 3 sales selling 12,125 shares for an estimated $1,656,956.
• ANUPAM KHARE (SVP/Chief Information Officer) sold 4,000 shares for an estimated $556,120
• BRYAN K BRANDT (SVP & Chief Marketing Officer) sold 1,731 shares for an estimated $243,058

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

OSK Hedge Fund Activity

We have seen 247 institutional investors add shares of OSK stock to their portfolio, and 308 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FULLER & THALER ASSET MANAGEMENT, INC. removed 583,083 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $66,203,243
• SG CAPITAL MANAGEMENT LLC added 557,006 shares (+inf%) to their portfolio in Q2 2025, for an estimated $63,242,461
• AMERICAN CENTURY COMPANIES INC added 529,907 shares (+22.8%) to their portfolio in Q2 2025, for an estimated $60,165,640
• PZENA INVESTMENT MANAGEMENT LLC added 525,887 shares (+inf%) to their portfolio in Q2 2025, for an estimated $59,709,209
• BLACKROCK, INC. added 524,179 shares (+8.4%) to their portfolio in Q2 2025, for an estimated $59,515,283
• UBS GROUP AG removed 449,022 shares (-66.1%) from their portfolio in Q2 2025, for an estimated $50,981,957
• BALYASNY ASSET MANAGEMENT L.P. removed 382,998 shares (-81.8%) from their portfolio in Q2 2025, for an estimated $43,485,592

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

OSK Analyst Ratings

Wall Street analysts have issued reports on $OSK in the last several months. We have seen 8 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Keybanc issued a "Overweight" rating on 08/26/2025
• UBS issued a "Buy" rating on 08/05/2025
• Baird issued a "Outperform" rating on 08/04/2025
• DA Davidson issued a "Buy" rating on 07/22/2025
• Goldman Sachs issued a "Buy" rating on 07/01/2025
• Citigroup issued a "Buy" rating on 06/24/2025
• B of A Securities issued a "Underperform" rating on 06/06/2025

To track analyst ratings and price targets for OSK, check out Quiver Quantitative's $OSK forecast page.

OSK Price Targets

Multiple analysts have issued price targets for $OSK recently. We have seen 11 analysts offer price targets for $OSK in the last 6 months, with a median target of $131.0.

Here are some recent targets:

• Steve Barger from Keybanc set a target price of $180.0 on 08/26/2025
• Michael Shlisky from DA Davidson set a target price of $160.0 on 08/05/2025
• Steven Fisher from UBS set a target price of $164.0 on 08/05/2025
• Mircea Dobre from Baird set a target price of $188.0 on 08/04/2025
• Jerry Revich from Goldman Sachs set a target price of $131.0 on 07/01/2025
• Kyle Menges from Citigroup set a target price of $130.0 on 06/24/2025
• Ross Gilardi from B of A Securities set a target price of $103.0 on 06/06/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$70,000 of ENERGIZER HOLDINGS INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"National Recycling Strategy; S.1008 - Setting Consumer Standards for Lithium-Ion Batteries Act; S.1194/H.R. 4040 - Recycling and Composting Accountability Act; S.1189 - Recycling Infrastructure and Accessibility Act of 2023. Congressional communications regarding battery and car care manufacturing, employment and sustainability issues; US-China competitiveness legislation regarding Generalized System of Preferences for manufacturing and trade with select developing countries for manufacturing/economic development purpose; H.R. 1 - One Big Beautiful Bill, Sec. 45X advanced manufacturing production tax credit language. Consumer safety issues and Consumer Product Safety Commission issues regarding battery safety. Congressional communications regarding battery and car care manufacturing, employment and sustainability issues; US-China competitiveness legislation regarding Generalized System of Preferences for manufacturing and trade with select developing countries for manufacturing/economic development purpose; H.R. 7024 - Tax Relief for American Families & Workers Act of 2024 re: manufacturing R&D tax credits. H.R. 1 - One Big Beautiful Bill, lobbying on Sec 45X advanced manufacturing production tax credit language."

You can find more data on corporate lobbying on Quiver Quantitative.

ENR Insider Trading Activity

ENR insiders have traded $ENR stock on the open market 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $ENR stock by insiders over the last 6 months:

• ROBERT V VITALE purchased 21,009 shares for an estimated $494,761
• DONAL L MULLIGAN purchased 10,000 shares for an estimated $236,600
• PATRICK J MOORE purchased 10,000 shares for an estimated $231,000
• KEVIN J HUNT purchased 5,000 shares for an estimated $114,250
• CYNTHIA J BRINKLEY purchased 4,000 shares for an estimated $92,480
• MARK STEPHEN LAVIGNE (President and CEO) purchased 4,000 shares for an estimated $86,680
• JOHN J DRABIK (EVP, Chief Financial Officer) purchased 1,000 shares for an estimated $23,860

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ENR Hedge Fund Activity

We have seen 135 institutional investors add shares of ENR stock to their portfolio, and 205 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FULLER & THALER ASSET MANAGEMENT, INC. added 1,802,664 shares (+86.1%) to their portfolio in Q2 2025, for an estimated $36,341,706
• ARMISTICE CAPITAL, LLC removed 592,144 shares (-52.5%) from their portfolio in Q2 2025, for an estimated $11,937,623
• CLARKSTON CAPITAL PARTNERS, LLC added 583,465 shares (+13.9%) to their portfolio in Q2 2025, for an estimated $11,762,654
• PRINCIPAL FINANCIAL GROUP INC removed 581,905 shares (-64.1%) from their portfolio in Q2 2025, for an estimated $11,731,204
• CITADEL ADVISORS LLC added 541,601 shares (+2892.4%) to their portfolio in Q2 2025, for an estimated $10,918,676
• MORGAN STANLEY added 539,774 shares (+66.9%) to their portfolio in Q2 2025, for an estimated $10,881,843
• BLACKROCK, INC. removed 537,688 shares (-5.2%) from their portfolio in Q2 2025, for an estimated $10,839,790

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ENR Analyst Ratings

Wall Street analysts have issued reports on $ENR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Truist Securities issued a "Buy" rating on 05/08/2025

To track analyst ratings and price targets for ENR, check out Quiver Quantitative's $ENR forecast page.

ENR Price Targets

Multiple analysts have issued price targets for $ENR recently. We have seen 5 analysts offer price targets for $ENR in the last 6 months, with a median target of $28.0.

Here are some recent targets:

• Bill Chappell from Truist Securities set a target price of $35.0 on 08/06/2025
• Lauren Lieberman from Barclays set a target price of $27.0 on 08/06/2025
• Peter Grom from UBS set a target price of $29.0 on 08/05/2025
• Andrea Teixeira from JP Morgan set a target price of $28.0 on 07/25/2025
• Brian McNamara from Canaccord Genuity set a target price of $27.0 on 05/07/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,570,000 of TAKEDA PHARMACEUTICALS AMERICA INC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"FY 2025 Budget Resolution - Pharmaceutical Related Provisions Policies to enhance patient access to medicines in Medicaid including rebate, waiver policy and funding issues Policies to enhance patient access to medicines in Medicare Proposals related to amending the protected classes in Medicare Medicare telehealth proposals CMS Transparency in Coverage Final Rule (CMS-9915-F) Medicare Drug Price Negotiation Program: Selected Drugs for Initial Price Applicability Year 2026 Medicare Drug Price Negotiation Program: Selected Drugs for Initial Price Applicability Year 2027 Medicare Drug Price Negotiation Program: Selected Drugs for Initial Price Applicability Year 2028 Discussions on spillover related to the IRA Discussions on reforming the Inflation Reduction Act Discussions on treatment of small molecule drugs related to Inflation Reduction Act Discussions on treatment of small molecule drugs related to Inflation Reduction Act H.R.1 492, S. 832, EPIC Act of 2025, All Pharmaceutical Related Provisions H.R. 946, Optimizing Research Progress Hope and New (ORPHAN) Cures Act Clarify or reform the 340B program Issues related to patient access of plasma therapies Global pharmaceutical supply chain operations and manufacturing locations Most Favored Nation/International Reference Pricing Issues related to rare disease diagnosis and access to care Issues related to Pharmacy Benefit Managers (PBMs) H.R. 1476, S. 694, PLASMA Act Administration's Global Tax Proposal General issues around 2025 Reconciliation/Inbound Concerns Issues related to proposed Tariffs - all pharmaceutical related provisions Discussions around Supply Chain implications"

You can find more data on corporate lobbying on Quiver Quantitative.

TAK Hedge Fund Activity

We have seen 180 institutional investors add shares of TAK stock to their portfolio, and 137 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MILLENNIUM MANAGEMENT LLC added 2,842,012 shares (+1152.2%) to their portfolio in Q2 2025, for an estimated $43,937,505
• UBS GROUP AG added 2,270,084 shares (+129.4%) to their portfolio in Q2 2025, for an estimated $35,095,498
• MORGAN STANLEY added 1,917,066 shares (+33.6%) to their portfolio in Q2 2025, for an estimated $29,637,840
• SOLEUS CAPITAL MANAGEMENT, L.P. removed 1,180,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $17,546,600
• BLACKROCK, INC. added 920,044 shares (+35.0%) to their portfolio in Q2 2025, for an estimated $14,223,880
• ADAGE CAPITAL PARTNERS GP, L.L.C. removed 899,298 shares (-26.2%) from their portfolio in Q2 2025, for an estimated $13,903,147
• VAN ECK ASSOCIATES CORP removed 840,952 shares (-38.7%) from their portfolio in Q2 2025, for an estimated $13,001,117

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$60,000 of FIRST SOLAR lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Prohibit China and other CCP-linked companies from accessing 45X tax credits."

You can find more data on corporate lobbying on Quiver Quantitative.

FSLR Congressional Stock Trading

Members of Congress have traded $FSLR stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $FSLR stock by members of Congress over the last 6 months:

• REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/08, 02/25.
• REPRESENTATIVE DAVE MIN sold up to $15,000 on 03/19.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

FSLR Insider Trading Activity

FSLR insiders have traded $FSLR stock on the open market 70 times in the past 6 months. Of those trades, 0 have been purchases and 70 have been sales.

Here’s a breakdown of recent trading of $FSLR stock by insiders over the last 6 months:

• MARK R WIDMAR (Chief Executive Officer) has made 0 purchases and 32 sales selling 54,809 shares for an estimated $9,079,981.
• MARKUS GLOECKLER (Chief Technology Officer) has made 0 purchases and 3 sales selling 10,315 shares for an estimated $1,582,896.
• ALEXANDER R. BRADLEY (Chief Financial Officer) has made 0 purchases and 4 sales selling 9,784 shares for an estimated $1,451,223.
• KUNTAL KUMAR VERMA (Chief Manufacturing Officer) has made 0 purchases and 14 sales selling 8,801 shares for an estimated $1,195,131.
• PATRICK JAMES BUEHLER (Chief Product Officer) has made 0 purchases and 4 sales selling 3,846 shares for an estimated $616,887.
• MICHAEL KORALEWSKI (Chief Supply Chain Officer) has made 0 purchases and 3 sales selling 3,412 shares for an estimated $528,387.
• JASON E. DYMBORT (General Counsel and Secretary) has made 0 purchases and 3 sales selling 2,507 shares for an estimated $483,860.
• NATHAN B. THEURER (VP - Global Controller and CAO) has made 0 purchases and 3 sales selling 752 shares for an estimated $133,675.
• CAROLINE STOCKDALE (Chief People and Comm. Officer) has made 0 purchases and 2 sales selling 568 shares for an estimated $75,790.
• GEORGES ANTOUN (Chief Commercial Officer) has made 0 purchases and 2 sales selling 376 shares for an estimated $50,173.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

FSLR Hedge Fund Activity

We have seen 476 institutional investors add shares of FSLR stock to their portfolio, and 463 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PRICE T ROWE ASSOCIATES INC /MD/ added 4,339,806 shares (+625.6%) to their portfolio in Q2 2025, for an estimated $718,411,485
• D. E. SHAW & CO., INC. removed 1,687,726 shares (-90.2%) from their portfolio in Q2 2025, for an estimated $279,386,162
• GOLDMAN SACHS GROUP INC removed 1,300,186 shares (-82.6%) from their portfolio in Q2 2025, for an estimated $215,232,790
• BLACKROCK, INC. added 1,097,952 shares (+9.3%) to their portfolio in Q2 2025, for an estimated $181,754,974
• CITADEL ADVISORS LLC added 910,803 shares (+485.9%) to their portfolio in Q2 2025, for an estimated $150,774,328
• VIKING GLOBAL INVESTORS LP added 854,919 shares (+60.6%) to their portfolio in Q2 2025, for an estimated $141,523,291
• UBS GROUP AG added 824,862 shares (+54.4%) to their portfolio in Q2 2025, for an estimated $136,547,655

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

FSLR Analyst Ratings

Wall Street analysts have issued reports on $FSLR in the last several months. We have seen 18 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• UBS issued a "Buy" rating on 08/05/2025
• BMO Capital issued a "Outperform" rating on 08/01/2025
• B of A Securities issued a "Buy" rating on 07/22/2025
• JP Morgan issued a "Overweight" rating on 07/22/2025
• Susquehanna issued a "Positive" rating on 07/21/2025
• Jefferies issued a "Buy" rating on 07/15/2025
• RBC Capital issued a "Outperform" rating on 07/01/2025

To track analyst ratings and price targets for FSLR, check out Quiver Quantitative's $FSLR forecast page.

FSLR Price Targets

Multiple analysts have issued price targets for $FSLR recently. We have seen 19 analysts offer price targets for $FSLR in the last 6 months, with a median target of $208.0.

Here are some recent targets:

• Joseph Osha from Guggenheim set a target price of $287.0 on 08/22/2025
• Gordon Johnson from GLJ Research set a target price of $214.06 on 08/12/2025
• Jon Windham from UBS set a target price of $275.0 on 08/05/2025
• Ameet Thakkar from BMO Capital set a target price of $203.0 on 08/01/2025
• Biju Perincheril from Susquehanna set a target price of $222.0 on 08/01/2025
• Mark Strouse from JP Morgan set a target price of $208.0 on 07/22/2025
• Dimple Gosai from B of A Securities set a target price of $201.0 on 07/22/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$20,000 of PG&E lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Energy and Utilites."

You can find more data on corporate lobbying on Quiver Quantitative.

PCG Congressional Stock Trading

Members of Congress have traded $PCG stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $PCG stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 02/26.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

PCG Insider Trading Activity

PCG insiders have traded $PCG stock on the open market 8 times in the past 6 months. Of those trades, 3 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $PCG stock by insiders over the last 6 months:

• MARLENE SANTOS sold 125,702 shares for an estimated $2,057,741
• CARLA J PETERMAN (EVP/Corp. Affairs & CSO) has made 0 purchases and 2 sales selling 65,040 shares for an estimated $1,094,947.
• JASON M GLICKMAN sold 40,239 shares for an estimated $632,154
• III MARK E FERGUSON sold 7,000 shares for an estimated $106,050
• LEO P DENAULT purchased 6,300 shares for an estimated $100,548
• RAJAT BAHRI purchased 3,170 shares for an estimated $50,054
• CARLOS M HERNANDEZ purchased 3,142 shares for an estimated $49,989

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

PCG Hedge Fund Activity

We have seen 422 institutional investors add shares of PCG stock to their portfolio, and 419 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO removed 65,729,195 shares (-53.2%) from their portfolio in Q2 2025, for an estimated $916,264,978
• FMR LLC removed 28,132,497 shares (-17.9%) from their portfolio in Q2 2025, for an estimated $392,167,008
• WELLINGTON MANAGEMENT GROUP LLP removed 13,917,050 shares (-52.6%) from their portfolio in Q2 2025, for an estimated $194,003,677
• BANK OF AMERICA CORP /DE/ added 10,352,477 shares (+91.4%) to their portfolio in Q2 2025, for an estimated $144,313,529
• PRICE T ROWE ASSOCIATES INC /MD/ added 8,632,819 shares (+29.9%) to their portfolio in Q2 2025, for an estimated $120,341,496
• AQR CAPITAL MANAGEMENT LLC added 8,212,761 shares (+49.9%) to their portfolio in Q2 2025, for an estimated $114,485,888
• COVALIS CAPITAL LLP added 7,935,782 shares (+2761.2%) to their portfolio in Q2 2025, for an estimated $110,624,801

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PCG Analyst Ratings

Wall Street analysts have issued reports on $PCG in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Morgan Stanley issued a "Underweight" rating on 05/22/2025
• Mizuho issued a "Outperform" rating on 05/19/2025
• Jefferies issued a "Buy" rating on 04/23/2025
• BMO Capital issued a "Outperform" rating on 04/14/2025
• Barclays issued a "Overweight" rating on 04/09/2025

To track analyst ratings and price targets for PCG, check out Quiver Quantitative's $PCG forecast page.

PCG Price Targets

Multiple analysts have issued price targets for $PCG recently. We have seen 9 analysts offer price targets for $PCG in the last 6 months, with a median target of $19.0.

Here are some recent targets:

• Nicholas Campanella from Barclays set a target price of $20.0 on 07/22/2025
• Stephen Byrd from Morgan Stanley set a target price of $18.0 on 05/22/2025
• Anthony Crowdell from Mizuho set a target price of $21.0 on 05/19/2025
• Michael Lonegan from Evercore ISI Group set a target price of $17.0 on 04/28/2025
• Shahriar Pourreza from Guggenheim set a target price of $17.0 on 04/25/2025
• Julien Dumoulin-Smith from Jefferies set a target price of $22.0 on 04/23/2025
• James Thalacker from BMO Capital set a target price of $22.0 on 04/14/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of KELLOGG HANSEN TODD FIGEL & FREDERICK ON BEHALF OF FUBOTV lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Antitrust; acquisition of FuboTV by the Walt Disney Company"

You can find more data on corporate lobbying on Quiver Quantitative.

FUBO Insider Trading Activity

FUBO insiders have traded $FUBO stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.

Here’s a breakdown of recent trading of $FUBO stock by insiders over the last 6 months:

• DANIEL V LEFF has made 0 purchases and 11 sales selling 260,788 shares for an estimated $990,121.
• EDGAR JR BRONFMAN (Executive Chairman) has made 0 purchases and 6 sales selling 119,388 shares for an estimated $435,390.
• LAURA DIANE ONOPCHENKO sold 100,000 shares for an estimated $392,000
• IGNACIO FIGUERAS sold 66,061 shares for an estimated $281,221
• JOHN JANEDIS (Chief Financial Officer) sold 25,823 shares for an estimated $107,423

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

FUBO Hedge Fund Activity

We have seen 123 institutional investors add shares of FUBO stock to their portfolio, and 119 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VANGUARD GROUP INC added 8,231,798 shares (+38.9%) to their portfolio in Q2 2025, for an estimated $31,774,740
• RENAISSANCE TECHNOLOGIES LLC added 7,548,900 shares (+99.8%) to their portfolio in Q2 2025, for an estimated $29,138,754
• D. E. SHAW & CO., INC. removed 6,255,433 shares (-51.5%) from their portfolio in Q2 2025, for an estimated $24,145,971
• TWO SIGMA INVESTMENTS, LP added 4,018,515 shares (+201.6%) to their portfolio in Q2 2025, for an estimated $15,511,467
• TWO SIGMA ADVISERS, LP added 3,399,000 shares (+564.8%) to their portfolio in Q2 2025, for an estimated $13,120,140
• UBS GROUP AG added 3,124,020 shares (+156.8%) to their portfolio in Q2 2025, for an estimated $12,058,717
• JUMP FINANCIAL, LLC added 2,436,479 shares (+189.6%) to their portfolio in Q2 2025, for an estimated $9,404,808

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

FUBO Analyst Ratings

Wall Street analysts have issued reports on $FUBO in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Wedbush issued a "Outperform" rating on 07/30/2025
• Needham issued a "Buy" rating on 07/30/2025

To track analyst ratings and price targets for FUBO, check out Quiver Quantitative's $FUBO forecast page.

FUBO Price Targets

Multiple analysts have issued price targets for $FUBO recently. We have seen 3 analysts offer price targets for $FUBO in the last 6 months, with a median target of $6.0.

Here are some recent targets:

• Alicia Reese from Wedbush set a target price of $6.0 on 07/30/2025
• Laura Martin from Needham set a target price of $4.25 on 07/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$20,000 of SOUTHEASTERN COMMUNITY COLLEGE lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"None"

You can find more data on corporate lobbying on Quiver Quantitative.

EML Insider Trading Activity

EML insiders have traded $EML stock on the open market 18 times in the past 6 months. Of those trades, 18 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $EML stock by insiders over the last 6 months:

• FREDERICK D. DISANTO has made 18 purchases buying 16,785 shares for an estimated $383,331 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

EML Hedge Fund Activity

We have seen 28 institutional investors add shares of EML stock to their portfolio, and 29 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VICTORY CAPITAL MANAGEMENT INC removed 46,835 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,068,774
• BLACKROCK, INC. added 27,438 shares (+9.6%) to their portfolio in Q2 2025, for an estimated $626,135
• SEGALL BRYANT & HAMILL, LLC removed 25,748 shares (-46.7%) from their portfolio in Q2 2025, for an estimated $587,569
• MINERVA ADVISORS LLC added 19,066 shares (+3.8%) to their portfolio in Q2 2025, for an estimated $435,086
• LOS ANGELES CAPITAL MANAGEMENT LLC added 14,274 shares (+inf%) to their portfolio in Q2 2025, for an estimated $325,732
• BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 9,480 shares (-12.6%) from their portfolio in Q2 2025, for an estimated $216,333
• GAMCO INVESTORS, INC. ET AL added 8,999 shares (+1.8%) to their portfolio in Q2 2025, for an estimated $205,357

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$85,000 of MCCORMICK & COMPANY INCORPORATED lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to tariffs Issues related to upcoming tax debate"

You can find more data on corporate lobbying on Quiver Quantitative.

MKC Congressional Stock Trading

Members of Congress have traded $MKC stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MKC stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 07/22.
• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MKC Insider Trading Activity

MKC insiders have traded $MKC stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $MKC stock by insiders over the last 6 months:

• LAWRENCE ERIK KURZIUS sold 50,000 shares for an estimated $4,090,300
• KATHERINE JENKINS (Chief Growth Officer) has made 0 purchases and 3 sales selling 7,642 shares for an estimated $583,696.
• MARITZA GOMEZ MONTIEL sold 5,912 shares for an estimated $488,745
• GREGORY REPAS (V.P. & Controller) sold 2,750 shares for an estimated $223,905

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MKC Hedge Fund Activity

We have seen 453 institutional investors add shares of MKC stock to their portfolio, and 561 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• SELECT EQUITY GROUP, L.P. removed 1,560,869 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $118,345,087
• FRANKLIN RESOURCES INC removed 1,533,979 shares (-31.8%) from their portfolio in Q2 2025, for an estimated $116,306,287
• WELLINGTON MANAGEMENT GROUP LLP added 1,465,917 shares (+706.1%) to their portfolio in Q2 2025, for an estimated $111,145,826
• MILLENNIUM MANAGEMENT LLC added 1,428,542 shares (+108.6%) to their portfolio in Q2 2025, for an estimated $108,312,054
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,297,316 shares (+31.4%) to their portfolio in Q2 2025, for an estimated $98,362,499
• GOLDMAN SACHS GROUP INC removed 1,205,306 shares (-51.1%) from their portfolio in Q2 2025, for an estimated $91,386,300
• INVESCO LTD. added 1,158,423 shares (+44.9%) to their portfolio in Q2 2025, for an estimated $87,831,631

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MKC Price Targets

Multiple analysts have issued price targets for $MKC recently. We have seen 4 analysts offer price targets for $MKC in the last 6 months, with a median target of $80.0.

Here are some recent targets:

• Thomas Palmer from JP Morgan set a target price of $83.0 on 08/20/2025
• Matthew Smith from Stifel set a target price of $76.0 on 07/29/2025
• Thomas Palmer from Citigroup set a target price of $77.0 on 06/17/2025
• Bryan Adams from UBS set a target price of $83.0 on 06/16/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of TRIMBLE INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Autonomous Self-Perception Combat Engineering Program (ASCEP II) Automated Pavement Inspection & Analysis for Military Airfields"

You can find more data on corporate lobbying on Quiver Quantitative.

TRMB Congressional Stock Trading

Members of Congress have traded $TRMB stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $TRMB stock by members of Congress over the last 6 months:

• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

TRMB Insider Trading Activity

TRMB insiders have traded $TRMB stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.

Here’s a breakdown of recent trading of $TRMB stock by insiders over the last 6 months:

• ROBERT G PAINTER (President & CEO) has made 0 purchases and 8 sales selling 238,847 shares for an estimated $19,750,811.
• KAIGHAM GABRIEL has made 0 purchases and 2 sales selling 12,514 shares for an estimated $892,626.
• CHRISTOPHER F KEATING (Sr. VP Transportation) sold 5,709 shares for an estimated $411,036
• RONALD BISIO (Sr. Vice President) has made 0 purchases and 2 sales selling 4,000 shares for an estimated $296,625.
• JENNIFER ALLISON (Corporate VP, General Counsel) sold 3,156 shares for an estimated $252,480
• MARK DAVID SCHWARTZ (Senior VP, AECO) has made 0 purchases and 2 sales selling 2,880 shares for an estimated $227,448.
• PETER LARGE (Senior Vice President) has made 0 purchases and 3 sales selling 3,000 shares for an estimated $204,314.
• JAMES CALVIN DALTON has made 0 purchases and 2 sales selling 2,837 shares for an estimated $203,814.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

TRMB Hedge Fund Activity

We have seen 379 institutional investors add shares of TRMB stock to their portfolio, and 366 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MACQUARIE GROUP LTD removed 2,188,735 shares (-93.0%) from their portfolio in Q2 2025, for an estimated $166,300,085
• THRIVENT FINANCIAL FOR LUTHERANS removed 2,062,587 shares (-97.3%) from their portfolio in Q2 2025, for an estimated $156,715,360
• GENERATION INVESTMENT MANAGEMENT LLP added 1,449,315 shares (+19.1%) to their portfolio in Q2 2025, for an estimated $110,118,953
• MORGAN STANLEY added 1,430,477 shares (+11.8%) to their portfolio in Q2 2025, for an estimated $108,687,642
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,375,513 shares (-19.7%) from their portfolio in Q2 2025, for an estimated $104,511,477
• JANE STREET GROUP, LLC removed 727,502 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $55,275,601
• SCHRODER INVESTMENT MANAGEMENT GROUP removed 638,956 shares (-94.6%) from their portfolio in Q2 2025, for an estimated $48,547,876

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TRMB Analyst Ratings

Wall Street analysts have issued reports on $TRMB in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Oppenheimer issued a "Outperform" rating on 08/07/2025
• Raymond James issued a "Outperform" rating on 08/07/2025
• JP Morgan issued a "Overweight" rating on 08/07/2025
• Piper Sandler issued a "Overweight" rating on 05/08/2025

To track analyst ratings and price targets for TRMB, check out Quiver Quantitative's $TRMB forecast page.

TRMB Price Targets

Multiple analysts have issued price targets for $TRMB recently. We have seen 4 analysts offer price targets for $TRMB in the last 6 months, with a median target of $93.5.

Here are some recent targets:

• Brian Gesuale from Raymond James set a target price of $93.0 on 08/07/2025
• Tami Zakaria from JP Morgan set a target price of $96.0 on 08/07/2025
• Kristen Owen from Oppenheimer set a target price of $94.0 on 08/07/2025
• Clarke Jeffries from Piper Sandler set a target price of $84.0 on 05/08/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$125,000 of COHERUS BIOSCIENCES INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act, Biosecure Act, Loans and grants for biologic production Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response."

You can find more data on corporate lobbying on Quiver Quantitative.

CHRS Insider Trading Activity

CHRS insiders have traded $CHRS stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CHRS stock by insiders over the last 6 months:

• MATS WAHLSTROM sold 99,988 shares for an estimated $73,881

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CHRS Hedge Fund Activity

We have seen 47 institutional investors add shares of CHRS stock to their portfolio, and 66 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• POINT72 ASSET MANAGEMENT, L.P. removed 5,283,292 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $4,263,616
• RUBRIC CAPITAL MANAGEMENT LP removed 4,390,954 shares (-83.5%) from their portfolio in Q2 2025, for an estimated $3,211,104
• MILLENNIUM MANAGEMENT LLC removed 1,517,799 shares (-52.3%) from their portfolio in Q2 2025, for an estimated $1,109,966
• PANAGORA ASSET MANAGEMENT INC added 794,329 shares (+inf%) to their portfolio in Q2 2025, for an estimated $580,892
• LOS ANGELES CAPITAL MANAGEMENT LLC removed 603,597 shares (-60.9%) from their portfolio in Q2 2025, for an estimated $441,410
• VANGUARD GROUP INC removed 581,390 shares (-5.2%) from their portfolio in Q2 2025, for an estimated $425,170
• DISCIPLINED GROWTH INVESTORS INC /MN removed 566,746 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $457,364

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CHRS Analyst Ratings

Wall Street analysts have issued reports on $CHRS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• HC Wainwright & Co. issued a "Buy" rating on 04/29/2025

To track analyst ratings and price targets for CHRS, check out Quiver Quantitative's $CHRS forecast page.

CHRS Price Targets

Multiple analysts have issued price targets for $CHRS recently. We have seen 2 analysts offer price targets for $CHRS in the last 6 months, with a median target of $4.025.

Here are some recent targets:

• Douglas Tsao from HC Wainwright & Co. set a target price of $7.0 on 04/29/2025
• Ashwani Verma from UBS set a target price of $1.05 on 04/24/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$3,710,000 of PFIZER INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"HR 1 - One Big Beautiful Bill Act CDC Reform Vaccine Policy Reconciliation Research & Development S 526 - Pharmacy Benefit Manager Transparency Act of 2025 S 832 - EPIC Act of 2025 HR 1 - One Big Beautiful Bill Act CDC Reform Vaccine Policy Reconciliation Research & Development HR 946 - ORPHAN Cures Act HR 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program HR 2214 - DRUG Act HR 2450 - Prescription Drug Transparency and Affordability Act PL 117-328 Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Biosimilars Access, Reimbursement and Reform 340B Reform Prescription Drug User Fee Act (PDUFA) Inflation Reduction Act (IRA) Pill Penalty Vaccine Coverage and Access Intellectual Property Protections PBM Reform Cancer Policies Drug Pricing S 526 - Pharmacy Benefit Manager Transparency Act of 2025 S 832 - EPIC Act of 2025 HR 946 - ORPHAN Cures Act HR 2450 - Prescription Drug Transparency and Affordability Act Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients PBM Reform Medicaid Prescription Drug Access Digital Therapeutics VICP Reform and Excise Tax Vaccine Injury Compensation Program International Supply Chain Global Access Tariffs Non-Tariff Trade Barriers"

You can find more data on corporate lobbying on Quiver Quantitative.

PFE Congressional Stock Trading

Members of Congress have traded $PFE stock 15 times in the past 6 months. Of those trades, 8 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 07/16.
• SENATOR RON WYDEN sold up to $15,000 on 06/03.
• REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 06/03.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 3 purchases worth up to $45,000 on 05/30, 04/29, 02/26 and 1 sale worth up to $50,000 on 03/31.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 3 times. They made 2 purchases worth up to $100,000 on 05/15, 02/25 and 1 sale worth up to $50,000 on 04/08.
• REPRESENTATIVE BRUCE WESTERMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/03 and 1 sale worth up to $15,000 on 04/21.
• REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 02/24 and 1 sale worth up to $50,000 on 04/11.
• REPRESENTATIVE CAROL D. MILLER sold up to $15,000 on 03/10.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

PFE Insider Trading Activity

PFE insiders have traded $PFE stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $PFE stock by insiders over the last 6 months:

• JENNIFER B. DAMICO (SVP & Controller) sold 2,500 shares for an estimated $64,825

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

PFE Hedge Fund Activity

We have seen 1,267 institutional investors add shares of PFE stock to their portfolio, and 1,638 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• WELLINGTON MANAGEMENT GROUP LLP removed 26,490,160 shares (-25.6%) from their portfolio in Q2 2025, for an estimated $642,121,478
• BLACKROCK, INC. added 20,709,704 shares (+4.4%) to their portfolio in Q2 2025, for an estimated $502,003,224
• AMUNDI removed 14,642,887 shares (-28.1%) from their portfolio in Q2 2025, for an estimated $354,943,580
• MARSHALL WACE, LLP removed 13,641,127 shares (-96.8%) from their portfolio in Q2 2025, for an estimated $330,660,918
• CAPITAL WORLD INVESTORS removed 13,368,274 shares (-49.1%) from their portfolio in Q2 2025, for an estimated $324,046,961
• QUBE RESEARCH & TECHNOLOGIES LTD removed 10,711,578 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $259,648,650
• VICTORY CAPITAL MANAGEMENT INC added 10,400,851 shares (+220.6%) to their portfolio in Q2 2025, for an estimated $252,116,628

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PFE Analyst Ratings

Wall Street analysts have issued reports on $PFE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Guggenheim issued a "Buy" rating on 03/18/2025

To track analyst ratings and price targets for PFE, check out Quiver Quantitative's $PFE forecast page.

PFE Price Targets

Multiple analysts have issued price targets for $PFE recently. We have seen 6 analysts offer price targets for $PFE in the last 6 months, with a median target of $25.5.

Here are some recent targets:

• Terence Flynn from Morgan Stanley set a target price of $33.0 on 08/06/2025
• Tim Anderson from B of A Securities set a target price of $28.0 on 08/06/2025
• Andrew Baum from Citigroup set a target price of $26.0 on 08/06/2025
• Trung Huynh from UBS set a target price of $25.0 on 04/30/2025
• Carter Gould from Cantor Fitzgerald set a target price of $24.0 on 04/22/2025
• Asad Haider from Goldman Sachs set a target price of $25.0 on 04/08/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of SOUTHEASTERN COLORADO WATER CONSERVANCY DISTRICT lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"monitoring funding for state revolving funds for safe drinking and clean water; any changes in how revolving funds work monitoring funding for Bureau of Reclamation and in particular the Arkansas Valley Conduit supporting legislation regarding the terms of payment of 35 percent cost of the Arkansas Valley Conduit; monitoring all Western water policy and regulatory issues"

You can find more data on corporate lobbying on Quiver Quantitative.

EML Insider Trading Activity

EML insiders have traded $EML stock on the open market 15 times in the past 6 months. Of those trades, 15 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $EML stock by insiders over the last 6 months:

• FREDERICK D. DISANTO has made 15 purchases buying 11,785 shares for an estimated $269,761 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

EML Hedge Fund Activity

We have seen 25 institutional investors add shares of EML stock to their portfolio, and 31 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VICTORY CAPITAL MANAGEMENT INC removed 46,835 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,068,774
• BLACKROCK, INC. added 27,438 shares (+9.6%) to their portfolio in Q2 2025, for an estimated $626,135
• SEGALL BRYANT & HAMILL, LLC removed 25,748 shares (-46.7%) from their portfolio in Q2 2025, for an estimated $587,569
• MINERVA ADVISORS LLC added 19,066 shares (+3.8%) to their portfolio in Q2 2025, for an estimated $435,086
• LOS ANGELES CAPITAL MANAGEMENT LLC added 14,274 shares (+inf%) to their portfolio in Q2 2025, for an estimated $325,732
• GAMCO INVESTORS, INC. ET AL added 8,999 shares (+1.8%) to their portfolio in Q2 2025, for an estimated $205,357
• BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 8,800 shares (-10.4%) from their portfolio in Q1 2025, for an estimated $222,816

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$80,000 of CLEANSPARK INC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Banking reform as it relates to digital assets Financial inclusion as it relates to digital assets Tax reform tariff issues related to imported goods Issues related to importing goods"

You can find more data on corporate lobbying on Quiver Quantitative.

CLSK Insider Trading Activity

CLSK insiders have traded $CLSK stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $CLSK stock by insiders over the last 6 months:

• ROGER PAUL BEYNON sold 50,000 shares for an estimated $525,285
• THOMAS LEIGH WOOD sold 44,444 shares for an estimated $357,329
• ZACHARY BRADFORD (CEO and President) sold 10,533 shares for an estimated $112,064
• AMANDA CAVALERI has made 0 purchases and 2 sales selling 13,000 shares for an estimated $103,600.
• S. MATTHEW SCHULTZ (Executive Chairman) sold 9,010 shares for an estimated $95,860
• SCOTT EUGENE GARRISON (Chief Operating Officer) sold 1,337 shares for an estimated $14,224
• GARY ANTHONY VECCHIARELLI (Chief Financial Officer) sold 717 shares for an estimated $7,628
• TAYLOR MONNIG (Chief Technology Officer) sold 239 shares for an estimated $2,542

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CLSK Hedge Fund Activity

We have seen 170 institutional investors add shares of CLSK stock to their portfolio, and 153 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GOLDMAN SACHS GROUP INC added 4,911,600 shares (+452.5%) to their portfolio in Q1 2025, for an estimated $33,005,952
• JANE STREET GROUP, LLC removed 4,495,966 shares (-98.9%) from their portfolio in Q1 2025, for an estimated $30,212,891
• STATE STREET CORP added 4,342,621 shares (+64.0%) to their portfolio in Q1 2025, for an estimated $29,182,413
• ASSENAGON ASSET MANAGEMENT S.A. removed 4,336,612 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $29,142,032
• MORGAN STANLEY removed 2,927,256 shares (-23.4%) from their portfolio in Q1 2025, for an estimated $19,671,160
• BANK OF AMERICA CORP /DE/ removed 2,776,210 shares (-80.8%) from their portfolio in Q1 2025, for an estimated $18,656,131
• DIMENSIONAL FUND ADVISORS LP added 2,560,425 shares (+1376.3%) to their portfolio in Q2 2025, for an estimated $28,241,487

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CLSK Analyst Ratings

Wall Street analysts have issued reports on $CLSK in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Chardan Capital issued a "Buy" rating on 08/12/2025
• B. Riley Securities issued a "Buy" rating on 08/08/2025
• Cantor Fitzgerald issued a "Overweight" rating on 08/08/2025
• Macquarie issued a "Outperform" rating on 08/08/2025
• Ladenburg Thalmann issued a "Buy" rating on 07/28/2025
• JP Morgan issued a "Overweight" rating on 07/28/2025

To track analyst ratings and price targets for CLSK, check out Quiver Quantitative's $CLSK forecast page.

CLSK Price Targets

Multiple analysts have issued price targets for $CLSK recently. We have seen 6 analysts offer price targets for $CLSK in the last 6 months, with a median target of $20.0.

Here are some recent targets:

• James McIlree from Chardan Capital set a target price of $20.0 on 08/12/2025
• Nick Giles from B. Riley Securities set a target price of $17.0 on 08/08/2025
• Paul Golding from Macquarie set a target price of $20.0 on 08/08/2025
• Brett Knoblauch from Cantor Fitzgerald set a target price of $26.0 on 08/08/2025
• Reginald Smith from JP Morgan set a target price of $15.0 on 07/28/2025
• Jon Hickman from Ladenburg Thalmann set a target price of $20.25 on 07/28/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$60,000 of KILROY REALTY lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"VISN 21 VA facilities modernization Marine Corps Air Station Miramar flight regulations Corporate State and Local Tax Deduction"

You can find more data on corporate lobbying on Quiver Quantitative.

KRC Hedge Fund Activity

We have seen 184 institutional investors add shares of KRC stock to their portfolio, and 173 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• COHEN & STEERS, INC. added 6,460,110 shares (+inf%) to their portfolio in Q1 2025, for an estimated $211,633,203
• FMR LLC added 5,859,607 shares (+37636.4%) to their portfolio in Q1 2025, for an estimated $191,960,725
• RESOLUTION CAPITAL LTD removed 3,792,242 shares (-84.5%) from their portfolio in Q1 2025, for an estimated $124,233,847
• D1 CAPITAL PARTNERS L.P. added 1,887,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $61,818,119
• RUSH ISLAND MANAGEMENT, LP added 1,731,637 shares (+64.0%) to their portfolio in Q1 2025, for an estimated $56,728,428
• PRICE T ROWE ASSOCIATES INC /MD/ removed 1,574,253 shares (-48.2%) from their portfolio in Q1 2025, for an estimated $51,572,528
• CENTERSQUARE INVESTMENT MANAGEMENT LLC removed 1,198,850 shares (-92.9%) from their portfolio in Q1 2025, for an estimated $39,274,326

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

KRC Analyst Ratings

Wall Street analysts have issued reports on $KRC in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• JP Morgan issued a "Overweight" rating on 07/02/2025
• Keybanc issued a "Overweight" rating on 03/31/2025
• Barclays issued a "Overweight" rating on 02/27/2025

To track analyst ratings and price targets for KRC, check out Quiver Quantitative's $KRC forecast page.

KRC Price Targets

Multiple analysts have issued price targets for $KRC recently. We have seen 11 analysts offer price targets for $KRC in the last 6 months, with a median target of $37.0.

Here are some recent targets:

• Michael Carroll from RBC Capital set a target price of $40.0 on 08/07/2025
• Steve Sakwa from Evercore ISI Group set a target price of $43.0 on 07/30/2025
• John Kim from BMO Capital set a target price of $35.0 on 07/16/2025
• Vikram Malhotra from Mizuho set a target price of $35.0 on 07/14/2025
• Nicholas Yulico from Scotiabank set a target price of $37.0 on 07/14/2025
• Anthony Paolone from JP Morgan set a target price of $40.0 on 07/02/2025
• Blaine Heck from Wells Fargo set a target price of $33.0 on 05/19/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$35,000 of SUNATION ENERGY lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Legislative initiative for HR1"

You can find more data on corporate lobbying on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$10,000 of WISDOMTREE DIGITAL MANAGEMENT INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to digital assets, including stablecoin legislation in the House (e.g., the STABLE Act (H.R.2392)) and in the Senate (e.g., the GENIUS Act (S.394/S.1582)). Issues related to digital assets, including crypto market structure legislation, H.R.3633 - Digital Asset Market Clarity Act of 2025."

You can find more data on corporate lobbying on Quiver Quantitative.

WT Hedge Fund Activity

We have seen 123 institutional investors add shares of WT stock to their portfolio, and 153 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• SIMCOE CAPITAL MANAGEMENT, LLC added 3,989,045 shares (+inf%) to their portfolio in Q1 2025, for an estimated $35,582,281
• MILLENNIUM MANAGEMENT LLC added 2,235,413 shares (+110.0%) to their portfolio in Q1 2025, for an estimated $19,939,883
• AZORA CAPITAL LP removed 1,506,982 shares (-14.2%) from their portfolio in Q1 2025, for an estimated $13,442,279
• MARSHALL WACE, LLP added 1,329,183 shares (+503.4%) to their portfolio in Q1 2025, for an estimated $11,856,312
• CITADEL ADVISORS LLC removed 1,118,100 shares (-62.8%) from their portfolio in Q1 2025, for an estimated $9,973,452
• NICHOLAS INVESTMENT PARTNERS, LP removed 726,427 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $6,479,728
• JANUS HENDERSON GROUP PLC added 690,230 shares (+35.9%) to their portfolio in Q1 2025, for an estimated $6,156,851

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

WT Analyst Ratings

Wall Street analysts have issued reports on $WT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Oppenheimer issued a "Outperform" rating on 07/22/2025

To track analyst ratings and price targets for WT, check out Quiver Quantitative's $WT forecast page.

WT Price Targets

Multiple analysts have issued price targets for $WT recently. We have seen 3 analysts offer price targets for $WT in the last 6 months, with a median target of $11.9.

Here are some recent targets:

• Chris Kotowski from Oppenheimer set a target price of $15.0 on 07/22/2025
• Michael Cyprys from Morgan Stanley set a target price of $11.0 on 07/02/2025
• Alexander Blostein from Goldman Sachs set a target price of $11.9 on 06/27/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of BROWNSTEIN HYATT FARBER AND SCHRECK ON BEHALF OF ROYAL CARIBBEAN CRUISES LTD lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"General issues related to cruise ship industry"

You can find more data on corporate lobbying on Quiver Quantitative.

RCL Congressional Stock Trading

Members of Congress have traded $RCL stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $RCL stock by members of Congress over the last 6 months:

• REPRESENTATIVE JEFFERSON SHREVE sold up to $100,000 on 05/12.
• REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 04/08.
• REPRESENTATIVE GEORGE WHITESIDES sold up to $250,000 on 03/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

RCL Insider Trading Activity

RCL insiders have traded $RCL stock on the open market 30 times in the past 6 months. Of those trades, 0 have been purchases and 30 have been sales.

Here’s a breakdown of recent trading of $RCL stock by insiders over the last 6 months:

• JASON T LIBERTY (President & CEO) has made 0 purchases and 5 sales selling 58,000 shares for an estimated $15,193,336.
• MICHAEL W BAYLEY (Pres&CEO, Royal Caribbean Intl) has made 0 purchases and 6 sales selling 49,134 shares for an estimated $12,876,586.
• RICHARD D FAIN has made 0 purchases and 4 sales selling 39,100 shares for an estimated $9,966,033.
• NAFTALI HOLTZ (Chief Financial Officer) has made 0 purchases and 4 sales selling 17,000 shares for an estimated $4,447,528.
• LAURA H BETHGE (President, Celebrity Cruises) has made 0 purchases and 5 sales selling 14,992 shares for an estimated $3,925,752.
• HENRY L PUJOL (Chief Accounting Officer) has made 0 purchases and 3 sales selling 5,207 shares for an estimated $1,715,549.
• ROBERT ALEXANDER LAKE (SVP, CLO, Secretary & CCO) has made 0 purchases and 2 sales selling 5,369 shares for an estimated $1,547,769.
• MARITZA GOMEZ MONTIEL sold 1,500 shares for an estimated $363,735

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

RCL Hedge Fund Activity

We have seen 624 institutional investors add shares of RCL stock to their portfolio, and 461 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL RESEARCH GLOBAL INVESTORS removed 4,903,316 shares (-17.4%) from their portfolio in Q1 2025, for an estimated $1,007,337,239
• CAPITAL INTERNATIONAL INVESTORS added 2,283,847 shares (+7.7%) to their portfolio in Q1 2025, for an estimated $469,193,527
• CAPITAL WORLD INVESTORS added 1,767,331 shares (+11.2%) to their portfolio in Q1 2025, for an estimated $363,080,480
• GAMMA INVESTING LLC removed 1,403,271 shares (-99.5%) from their portfolio in Q2 2025, for an estimated $439,420,280
• CITADEL ADVISORS LLC removed 865,553 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $177,819,208
• WELLINGTON MANAGEMENT GROUP LLP removed 775,106 shares (-75.7%) from their portfolio in Q1 2025, for an estimated $159,237,776
• PRIMECAP MANAGEMENT CO/CA/ removed 719,890 shares (-16.9%) from their portfolio in Q1 2025, for an estimated $147,894,201

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

RCL Analyst Ratings

Wall Street analysts have issued reports on $RCL in the last several months. We have seen 12 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Citigroup issued a "Buy" rating on 07/30/2025
• Stifel issued a "Buy" rating on 07/30/2025
• JP Morgan issued a "Overweight" rating on 07/30/2025
• Susquehanna issued a "Positive" rating on 07/30/2025
• TD Cowen issued a "Buy" rating on 07/22/2025
• Barclays issued a "Overweight" rating on 07/09/2025
• Bernstein issued a "Outperform" rating on 07/02/2025

To track analyst ratings and price targets for RCL, check out Quiver Quantitative's $RCL forecast page.

RCL Price Targets

Multiple analysts have issued price targets for $RCL recently. We have seen 15 analysts offer price targets for $RCL in the last 6 months, with a median target of $355.0.

Here are some recent targets:

• Matthew Boss from JP Morgan set a target price of $367.0 on 07/30/2025
• Steven Wieczynski from Stifel set a target price of $420.0 on 07/30/2025
• Christopher Stathoulopoulos from Susquehanna set a target price of $385.0 on 07/30/2025
• James Hardiman from Citigroup set a target price of $399.0 on 07/30/2025
• Andrew Didora from B of A Securities set a target price of $355.0 on 07/23/2025
• Kevin Kopelman from TD Cowen set a target price of $405.0 on 07/22/2025
• Patrick Scholes from Truist Securities set a target price of $337.0 on 07/21/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$430,000 of ECOLAB INC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Discussions related to environmental policies and issues including water infrastructure, water reuse, water efficiency, water resource management, and sustainability. Discussions related to energy and water efficiency initiatives. Discussions related to PFAS remediation technology. Discussions related to the implementation of the Pesticide Registration Improvement Act, P.L.117-103. Discussions related to data center water efficiency and energy efficiency. Discussions regarding scope of Sec. 48D investment tax credit; Discussions related to the extension of the Tax Cuts and Jobs Act (P.L.115-97); H.R.1, One Big Beautiful Bill Act. Discussions related to supply chain challenges. Discussions regarding trade policy and tariffs. Discussions regarding sustainable aviation fuel. Discussions regarding permitting reform. Discussions regarding Department of Energy programs for Critical Mineral production, including the use of resins as extraction technology. Discussions regarding biopharmaceutical manufacturing policy. Discussions regarding resin bead manufacturing technology."

You can find more data on corporate lobbying on Quiver Quantitative.

ECL Congressional Stock Trading

Members of Congress have traded $ECL stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $ECL stock by members of Congress over the last 6 months:

• REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $250,000 on 04/07 and 1 sale worth up to $250,000 on 05/08.
• SENATOR JOHN BOOZMAN purchased up to $15,000 on 02/26.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

ECL Insider Trading Activity

ECL insiders have traded $ECL stock on the open market 10 times in the past 6 months. Of those trades, 2 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $ECL stock by insiders over the last 6 months:

• LARRY L BERGER (EVP & CHIEF TECHNICAL OFFICER) sold 10,858 shares for an estimated $2,898,575
• NICHOLAS J. ALFANO (EVP & PRES - GLOBAL INDUSTRIAL) sold 9,930 shares for an estimated $2,519,737
• MACHIEL DUIJSER (EVP & CSCO) sold 5,721 shares for an estimated $1,510,572
• GREGORY B COOK (EVP & PRES - INST GROUP) sold 2,234 shares for an estimated $565,202
• ARTHUR J HIGGINS sold 1,800 shares for an estimated $473,490
• TRACY B MCKIBBEN sold 1,704 shares for an estimated $451,035
• VICTORIA REICH sold 1,300 shares for an estimated $352,300
• DAVID MACLENNAN has made 2 purchases buying 900 shares for an estimated $231,678 and 0 sales.
• JENNIFER J BRADWAY (SVP & CORPORATE CONTROLLER) sold 856 shares for an estimated $228,866

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ECL Hedge Fund Activity

We have seen 703 institutional investors add shares of ECL stock to their portfolio, and 721 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GAMMA INVESTING LLC removed 1,805,741 shares (-99.6%) from their portfolio in Q2 2025, for an estimated $486,538,855
• VONTOBEL HOLDING LTD. added 1,109,585 shares (+119.7%) to their portfolio in Q2 2025, for an estimated $298,966,582
• MORGAN STANLEY added 1,083,941 shares (+18.4%) to their portfolio in Q1 2025, for an estimated $274,800,722
• AUTO-OWNERS INSURANCE CO removed 996,400 shares (-99.6%) from their portfolio in Q2 2025, for an estimated $268,470,016
• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 816,729 shares (+47.9%) to their portfolio in Q1 2025, for an estimated $207,057,136
• UBS GROUP AG added 685,184 shares (+77.2%) to their portfolio in Q1 2025, for an estimated $173,707,847
• FIRST TRUST ADVISORS LP added 663,591 shares (+175.3%) to their portfolio in Q1 2025, for an estimated $168,233,590

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ECL Analyst Ratings

Wall Street analysts have issued reports on $ECL in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Baird issued a "Outperform" rating on 07/30/2025
• Citigroup issued a "Buy" rating on 07/30/2025
• Mizuho issued a "Outperform" rating on 07/15/2025
• Stifel issued a "Buy" rating on 04/30/2025
• Seaport Global issued a "Buy" rating on 04/21/2025
• Barclays issued a "Overweight" rating on 04/17/2025
• BMO Capital issued a "Outperform" rating on 03/03/2025

To track analyst ratings and price targets for ECL, check out Quiver Quantitative's $ECL forecast page.

ECL Price Targets

Multiple analysts have issued price targets for $ECL recently. We have seen 11 analysts offer price targets for $ECL in the last 6 months, with a median target of $300.0.

Here are some recent targets:

• Patrick Cunningham from Citigroup set a target price of $315.0 on 07/30/2025
• Andrew Wittmann from Baird set a target price of $300.0 on 07/30/2025
• John Roberts from Mizuho set a target price of $305.0 on 07/15/2025
• Joshua Spector from UBS set a target price of $288.0 on 07/09/2025
• Jason Haas from Wells Fargo set a target price of $260.0 on 05/20/2025
• Shlomo Rosenbaum from Stifel set a target price of $303.0 on 04/30/2025
• Michael Harrison from Seaport Global set a target price of $290.0 on 04/21/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,780,000 of SOUTHERN COMPANY lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"None. Drone/UAV issues, generally; None. Middle-mile broadband infrastructure issues, generally; Spectrum issues, generally, including the FCC's 6 GHz spectrum proposal and Cruz-Thune spectrum pipeline bill; Pole attachment issues, generally; None. Climate change issues, generally; Environmental regulation, generally (Effluent Limitations Guidelines; Good Neighbor Ozone Transport; CAA Sec. 111 rulemaking) S.J.Res. 4, tankless water heater CRA; H.J.Res. 20, tankless water heater CRA; DOE Distribution Transformer Rule; Grid enhancing technologies, generally; Issues related to FERCs transmission planning and cost allocation rule (Order 1920); Issues related to FERCs regional transmission organizations, generally; Issues related to deregulation, generally; DOE Loan Program Office issues, generally (1706); Issues related to Transmission legislation, generally; Issues related to Grid enhancing technologies, generally; Issues related to Natural gas infrastructure development, generally; Issues related to Energy infrastructure development, generally; Issues related to FERC nominations, generally; Issues related to S.2651, the SITE Act; Issues related to Building American Energy Security Act of 2023; Issues related to regional transmission organizations, generally; Issues related to deregulation generally; Issues related to interconnection, generally; Issues related to DOE Loan Program Office, generally; Issues related to wildfires, generally; H.R. 7624, Advancing Grid-Enhancing Technologies Act of 2024; H.R. 4476, PURPA Modernization Act of 2017; H.R. 1897, ESA Amendments of 2025; S.1449 RESTART Act; Issues related to HR 1, generally; Issues related to NEPA and permitting reform, generally; Issues related to Yucca Mountain used fuel repository; Issues related to used fuel management; Issues related to consent-based siting generally; Issues related to AP1000 technology generally; Issues related to Accident Tolerant Fuel program; Issues related to advanced nuclear technology; Issues related to DOE Advanced Reactor Development Program, generally; Issues related to small modular reactors (SMRs) in general; Issues related to natural gas stoves; Issues related to DOE energy efficiency standards for electric distribution transformers; DOE new nuclear R&D programs, generally; NRC fee issues, generally; Issues related to NRC nominees in general; Issues related to the NRC decision on Subsequent License Renewal; Issues related to Subsequent License Renewal, generally; Issues related to nuclear uprates, generally; Issues related to nuclear fuels; Issues related to HAELU fuel; Issues related to distribution transformers, generally; The ADVANCE Act, P.L. 118-67; None. Budget reconciliation, generally; Energy R&D funding; Low Income Home Energy Assistance Program (LIHEAP) funding; FY2025 Energy and Water Development and Related Agencies Appropriations bills, generally; Issues related to the Department of Government Efficiency, generally; Climate change issues, generally; Environmental regulation, generally; Clean Water Act, generally; Nationwide Permit Program, generally (Clean Water Act Section 404); NEPA Phase II Proposed Rule and NEPA issues, generally; ESA regulations, generally; Issues related to wildfires, generally; Tax Cuts and Jobs Act issues; generally; Inflation Reduction Act Implementation, generally; One Big Beautiful Bill Acct, generally;"

You can find more data on corporate lobbying on Quiver Quantitative.

SO Congressional Stock Trading

Members of Congress have traded $SO stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $SO stock by members of Congress over the last 6 months:

• REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 04/07.
• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 04/03.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

SO Insider Trading Activity

SO insiders have traded $SO stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $SO stock by insiders over the last 6 months:

• KIMBERLY S, GREENE (Chairman, President & CEO, GPC) has made 0 purchases and 2 sales selling 45,348 shares for an estimated $4,247,542.
• CHRISTOPHER C WOMACK (Chairman, President & CEO) has made 0 purchases and 2 sales selling 26,000 shares for an estimated $2,343,172.
• JAMES JEFFREY PEOPLES (Chairman, President & CEO, APC) sold 14,540 shares for an estimated $1,250,440
• STAN W CONNALLY (EVP & COO) sold 12,500 shares for an estimated $1,153,000
• CHRISTOPHER CUMMISKEY (EVP) sold 12,335 shares for an estimated $1,104,475
• MARTIN BERNARD DAVIS (EVP & CIO) sold 1,125 shares for an estimated $100,811

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

SO Hedge Fund Activity

We have seen 1,043 institutional investors add shares of SO stock to their portfolio, and 879 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GQG PARTNERS LLC removed 14,751,176 shares (-99.7%) from their portfolio in Q1 2025, for an estimated $1,356,370,633
• JPMORGAN CHASE & CO added 7,777,361 shares (+13.9%) to their portfolio in Q1 2025, for an estimated $715,128,343
• SOROBAN CAPITAL PARTNERS LP added 2,229,510 shares (+inf%) to their portfolio in Q1 2025, for an estimated $205,003,444
• CITADEL ADVISORS LLC added 2,208,783 shares (+974.0%) to their portfolio in Q1 2025, for an estimated $203,097,596
• GAMMA INVESTING LLC removed 1,928,734 shares (-98.7%) from their portfolio in Q2 2025, for an estimated $177,115,643
• BANK OF AMERICA CORP /DE/ added 1,927,867 shares (+26.8%) to their portfolio in Q1 2025, for an estimated $177,267,370
• CAPITAL INTERNATIONAL INVESTORS removed 1,472,917 shares (-5.4%) from their portfolio in Q1 2025, for an estimated $135,434,718

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SO Analyst Ratings

Wall Street analysts have issued reports on $SO in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Scotiabank issued a "Sector Outperform" rating on 08/01/2025
• BMO Capital issued a "Outperform" rating on 07/22/2025
• Raymond James issued a "Outperform" rating on 06/13/2025
• Jefferies issued a "Buy" rating on 06/05/2025
• Keybanc issued a "Underweight" rating on 05/14/2025

To track analyst ratings and price targets for SO, check out Quiver Quantitative's $SO forecast page.

SO Price Targets

Multiple analysts have issued price targets for $SO recently. We have seen 13 analysts offer price targets for $SO in the last 6 months, with a median target of $97.0.

Here are some recent targets:

• Anthony Crowdell from Mizuho set a target price of $95.0 on 08/01/2025
• Andrew Weisel from Scotiabank set a target price of $99.0 on 08/01/2025
• James Thalacker from BMO Capital set a target price of $102.0 on 07/22/2025
• Nicholas Campanella from Barclays set a target price of $91.0 on 07/16/2025
• Jeremy Tonet from JP Morgan set a target price of $97.0 on 07/15/2025
• Stephen Byrd from Morgan Stanley set a target price of $90.0 on 06/18/2025
• J.R. Weston from Raymond James set a target price of $98.0 on 06/13/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$15,000 of AEMETIS INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Section 45Z extension Section 45Z production tax credit"

You can find more data on corporate lobbying on Quiver Quantitative.

AMTX Hedge Fund Activity

We have seen 30 institutional investors add shares of AMTX stock to their portfolio, and 41 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JANE STREET GROUP, LLC removed 374,016 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $650,787
• VANGUARD GROUP INC added 218,471 shares (+10.1%) to their portfolio in Q1 2025, for an estimated $380,139
• SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 133,593 shares (-31.3%) from their portfolio in Q1 2025, for an estimated $232,451
• GSA CAPITAL PARTNERS LLP added 126,282 shares (+inf%) to their portfolio in Q2 2025, for an estimated $313,179
• CITADEL ADVISORS LLC removed 121,684 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $211,730
• JPMORGAN CHASE & CO removed 99,720 shares (-82.6%) from their portfolio in Q1 2025, for an estimated $173,512
• GOLDMAN SACHS GROUP INC added 91,367 shares (+71.9%) to their portfolio in Q1 2025, for an estimated $158,978

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AMTX Analyst Ratings

Wall Street analysts have issued reports on $AMTX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• UBS issued a "Buy" rating on 06/30/2025
• Ascendiant Capital issued a "Buy" rating on 06/06/2025
• HC Wainwright & Co. issued a "Buy" rating on 03/14/2025

To track analyst ratings and price targets for AMTX, check out Quiver Quantitative's $AMTX forecast page.

AMTX Price Targets

Multiple analysts have issued price targets for $AMTX recently. We have seen 3 analysts offer price targets for $AMTX in the last 6 months, with a median target of $20.0.

Here are some recent targets:

• Manav Gupta from UBS set a target price of $3.0 on 06/30/2025
• Edward Woo from Ascendiant Capital set a target price of $20.0 on 06/06/2025
• Amit Dayal from HC Wainwright & Co. set a target price of $28.0 on 03/14/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$17,500 of ECHOSTAR CORPORATION/DBA DISH lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to the wireless industry, including spectrum and Open RAN/direct-to-device technologies"

You can find more data on corporate lobbying on Quiver Quantitative.

SATS Insider Trading Activity

SATS insiders have traded $SATS stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $SATS stock by insiders over the last 6 months:

• DEAN MANSON (CHIEF LEGAL OFFICER) has made 0 purchases and 2 sales selling 30,000 shares for an estimated $975,250.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

SATS Hedge Fund Activity

We have seen 150 institutional investors add shares of SATS stock to their portfolio, and 129 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BLACKROCK, INC. removed 4,410,496 shares (-21.2%) from their portfolio in Q1 2025, for an estimated $112,820,487
• GOLDENTREE ASSET MANAGEMENT LP added 1,789,238 shares (+824.7%) to their portfolio in Q1 2025, for an estimated $45,768,708
• UBS GROUP AG added 1,713,729 shares (+97.8%) to their portfolio in Q1 2025, for an estimated $43,837,187
• INVESCO LTD. removed 1,599,496 shares (-69.5%) from their portfolio in Q1 2025, for an estimated $40,915,107
• CITADEL ADVISORS LLC added 1,413,813 shares (+467.5%) to their portfolio in Q1 2025, for an estimated $36,165,336
• DIAMETER CAPITAL PARTNERS LP added 999,000 shares (+19.9%) to their portfolio in Q1 2025, for an estimated $25,554,420
• DEUTSCHE BANK AG\ added 924,184 shares (+98.2%) to their portfolio in Q1 2025, for an estimated $23,640,626

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$420,000 of LANTHEUS HOLDINGS INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"HOPPS separate payment for diagnostic radiopharmaceuticals"

You can find more data on corporate lobbying on Quiver Quantitative.

LNTH Insider Trading Activity

LNTH insiders have traded $LNTH stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.

Here’s a breakdown of recent trading of $LNTH stock by insiders over the last 6 months:

• MARY ANNE HEINO has made 0 purchases and 8 sales selling 79,175 shares for an estimated $7,013,504.
• ROBERT J. JR. MARSHALL (CFO and Treasurer) has made 0 purchases and 4 sales selling 49,773 shares for an estimated $4,306,495.
• DANIEL NIEDZWIECKI (See Remarks) has made 0 purchases and 2 sales selling 12,000 shares for an estimated $950,340.
• PAUL BLANCHFIELD (President) has made 0 purchases and 2 sales selling 8,683 shares for an estimated $729,842.
• JULIE MCHUGH sold 5,192 shares for an estimated $423,771

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

LNTH Hedge Fund Activity

We have seen 246 institutional investors add shares of LNTH stock to their portfolio, and 241 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FARALLON CAPITAL MANAGEMENT LLC added 707,000 shares (+13.3%) to their portfolio in Q1 2025, for an estimated $69,003,200
• WELLINGTON MANAGEMENT GROUP LLP added 685,290 shares (+306.2%) to their portfolio in Q1 2025, for an estimated $66,884,303
• BNP PARIBAS FINANCIAL MARKETS added 418,515 shares (+1043.6%) to their portfolio in Q1 2025, for an estimated $40,847,064
• EPOCH INVESTMENT PARTNERS, INC. added 364,219 shares (+inf%) to their portfolio in Q1 2025, for an estimated $35,547,774
• ASSENAGON ASSET MANAGEMENT S.A. removed 336,237 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $27,524,360
• JANUS HENDERSON GROUP PLC added 315,763 shares (+5.1%) to their portfolio in Q1 2025, for an estimated $30,818,468
• JPMORGAN CHASE & CO added 315,517 shares (+56.0%) to their portfolio in Q1 2025, for an estimated $30,794,459

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

LNTH Analyst Ratings

Wall Street analysts have issued reports on $LNTH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• B. Riley Securities issued a "Buy" rating on 06/23/2025
• Truist Securities issued a "Buy" rating on 05/08/2025

To track analyst ratings and price targets for LNTH, check out Quiver Quantitative's $LNTH forecast page.

LNTH Price Targets

Multiple analysts have issued price targets for $LNTH recently. We have seen 2 analysts offer price targets for $LNTH in the last 6 months, with a median target of $113.0.

Here are some recent targets:

• Justin Walsh from B. Riley Securities set a target price of $109.0 on 06/23/2025
• Richard Newitter from Truist Securities set a target price of $117.0 on 05/08/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$15,000 of AXOGEN INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues relating to sensation loss after mastectomy."

You can find more data on corporate lobbying on Quiver Quantitative.

AXGN Insider Trading Activity

AXGN insiders have traded $AXGN stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $AXGN stock by insiders over the last 6 months:

• JOSEPH A. TYNDALL has made 0 purchases and 4 sales selling 49,518 shares for an estimated $542,760.
• ERICK WAYNE DEVINNEY (Chief Innovation Officer) sold 15,111 shares for an estimated $264,442
• AMY MCBRIDE WENDELL has made 0 purchases and 2 sales selling 9,073 shares for an estimated $143,314.
• GUIDO J NEELS sold 4,073 shares for an estimated $43,214
• JOHN JOHNSON sold 4,073 shares for an estimated $43,214
• WILLIAM P. MR. BURKE sold 4,073 shares for an estimated $43,214
• ALAN M LEVINE sold 4,073 shares for an estimated $43,214
• KATHY JOHNSON WEILER sold 4,073 shares for an estimated $43,214

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AXGN Hedge Fund Activity

We have seen 96 institutional investors add shares of AXGN stock to their portfolio, and 72 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• SOLEUS CAPITAL MANAGEMENT, L.P. removed 1,509,826 shares (-51.1%) from their portfolio in Q1 2025, for an estimated $27,931,781
• WASATCH ADVISORS LP added 774,633 shares (+inf%) to their portfolio in Q1 2025, for an estimated $14,330,710
• ARROWMARK COLORADO HOLDINGS LLC removed 657,689 shares (-29.2%) from their portfolio in Q1 2025, for an estimated $12,167,246
• MARSHALL WACE, LLP added 576,664 shares (+629.6%) to their portfolio in Q1 2025, for an estimated $10,668,284
• BALYASNY ASSET MANAGEMENT L.P. added 380,248 shares (+126.8%) to their portfolio in Q1 2025, for an estimated $7,034,588
• INVESCO LTD. added 365,237 shares (+2124.5%) to their portfolio in Q1 2025, for an estimated $6,756,884
• QUBE RESEARCH & TECHNOLOGIES LTD added 282,700 shares (+191.5%) to their portfolio in Q1 2025, for an estimated $5,229,950

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AXGN Analyst Ratings

Wall Street analysts have issued reports on $AXGN in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Canaccord Genuity issued a "Buy" rating on 05/13/2025
• Lake Street issued a "Buy" rating on 03/17/2025
• Cantor Fitzgerald issued a "Overweight" rating on 03/05/2025
• Citizens Capital Markets issued a "Market Outperform" rating on 03/05/2025

To track analyst ratings and price targets for AXGN, check out Quiver Quantitative's $AXGN forecast page.

AXGN Price Targets

Multiple analysts have issued price targets for $AXGN recently. We have seen 5 analysts offer price targets for $AXGN in the last 6 months, with a median target of $26.0.

Here are some recent targets:

• Caitlin Cronin from Canaccord Genuity set a target price of $24.0 on 05/13/2025
• Frank Takkinen from Lake Street set a target price of $30.0 on 03/17/2025
• Ross Osborn from Cantor Fitzgerald set a target price of $24.0 on 03/05/2025
• David Turkaly from Citizens Capital Markets set a target price of $26.0 on 03/05/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$200,000 of FREEDOM HOLDING CORP lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Matters relating to financial services. Support for the development of critical minerals in Kazakhstan. HR 1024, US-Kazakhstan Trade Modernization Act."

You can find more data on corporate lobbying on Quiver Quantitative.

FRHC Insider Trading Activity

FRHC insiders have traded $FRHC stock on the open market 19 times in the past 6 months. Of those trades, 1 have been purchases and 18 have been sales.

Here’s a breakdown of recent trading of $FRHC stock by insiders over the last 6 months:

• EVGENY LER (Chief Financial Officer) has made 0 purchases and 5 sales selling 20,000 shares for an estimated $78,223,895.
• ROBERT WOTCZAK (Pres & CEO - Prime Executions) has made 0 purchases and 5 sales selling 20,000 shares for an estimated $3,134,710.
• SERGEY LUKYANOV (*See Remarks) has made 0 purchases and 4 sales selling 7,901 shares for an estimated $1,243,913.
• AIDOS ZHUMAGULOV (*See Remarks) has made 0 purchases and 2 sales selling 6,927 shares for an estimated $1,009,050.
• RENAT TUKANOV (CHIEF TECHNOLOGY OFFICER) has made 0 purchases and 2 sales selling 3,000 shares for an estimated $429,024.
• ASKAR TASHTITOV (President) purchased 600 shares for an estimated $84,450

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

FRHC Hedge Fund Activity

We have seen 61 institutional investors add shares of FRHC stock to their portfolio, and 29 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MILLENNIUM MANAGEMENT LLC added 105,641 shares (+648.1%) to their portfolio in Q1 2025, for an estimated $13,962,570
• MARSHALL WACE, LLP removed 54,942 shares (-67.8%) from their portfolio in Q1 2025, for an estimated $7,261,684
• GOLDMAN SACHS GROUP INC added 51,159 shares (+214.4%) to their portfolio in Q1 2025, for an estimated $6,761,685
• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 50,122 shares (+1380.8%) to their portfolio in Q1 2025, for an estimated $6,624,624
• CITADEL ADVISORS LLC removed 39,821 shares (-99.2%) from their portfolio in Q1 2025, for an estimated $5,263,141
• HRT FINANCIAL LP added 39,602 shares (+141.2%) to their portfolio in Q1 2025, for an estimated $5,234,196
• BANK OF NEW YORK MELLON CORP added 33,568 shares (+467.0%) to their portfolio in Q2 2025, for an estimated $4,902,606

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of PRIDE MOBILITY PRODUCTS CORP lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"DME industry relief, wheelchair upgrade legislation, Medicare coverage for power standing systems, wheelchair repair & service reform, tariffs on medical devices."

You can find more data on corporate lobbying on Quiver Quantitative.

CTS Hedge Fund Activity

We have seen 92 institutional investors add shares of CTS stock to their portfolio, and 99 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 176,743 shares (-8.0%) from their portfolio in Q1 2025, for an estimated $7,343,671
• AMERIPRISE FINANCIAL INC added 142,863 shares (+193.1%) to their portfolio in Q1 2025, for an estimated $5,935,957
• WELLINGTON MANAGEMENT GROUP LLP removed 124,810 shares (-20.0%) from their portfolio in Q1 2025, for an estimated $5,185,855
• BLACKROCK, INC. removed 106,565 shares (-2.2%) from their portfolio in Q1 2025, for an estimated $4,427,775
• UNIPLAN INVESTMENT COUNSEL, INC. removed 103,545 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $4,302,294
• QUBE RESEARCH & TECHNOLOGIES LTD added 97,304 shares (+312.1%) to their portfolio in Q1 2025, for an estimated $4,042,981
• WEISS ASSET MANAGEMENT LP removed 92,546 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $3,845,286

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$50,000 of APPLIED OPTOELECTRONICS INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to trade. H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; S.2296 - National Defense Authorization Act for Fiscal Year 2026."

You can find more data on corporate lobbying on Quiver Quantitative.

AAOI Insider Trading Activity

AAOI insiders have traded $AAOI stock on the open market 9 times in the past 6 months. Of those trades, 2 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $AAOI stock by insiders over the last 6 months:

• HUNG-LUN (FRED) CHANG (*** See Remarks) sold 23,837 shares for an estimated $454,278
• CHIH-HSIANG (THOMPSON) LIN (President and CEO) has made 2 purchases buying 21,200 shares for an estimated $386,221 and 0 sales.
• STEFAN J. MURRY (Chief Financial Officer) has made 0 purchases and 5 sales selling 11,000 shares for an estimated $221,193.
• DAVID C KUO (*** See Remarks) sold 11,426 shares for an estimated $218,213

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AAOI Hedge Fund Activity

We have seen 93 institutional investors add shares of AAOI stock to their portfolio, and 78 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JAT CAPITAL MGMT LP removed 1,851,730 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $28,424,055
• ASSENAGON ASSET MANAGEMENT S.A. removed 976,520 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $25,086,798
• OBERWEIS ASSET MANAGEMENT INC/ added 889,026 shares (+179.3%) to their portfolio in Q1 2025, for an estimated $13,646,549
• YONG RONG (HK) ASSET MANAGEMENT LTD removed 750,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $11,512,500
• POINT72 HONG KONG LTD added 742,734 shares (+inf%) to their portfolio in Q1 2025, for an estimated $11,400,966
• JEFFERIES FINANCIAL GROUP INC. removed 633,600 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $9,725,760
• UBS GROUP AG added 515,486 shares (+126.7%) to their portfolio in Q1 2025, for an estimated $7,912,710

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AAOI Analyst Ratings

Wall Street analysts have issued reports on $AAOI in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Needham issued a "Buy" rating on 07/25/2025
• Rosenblatt issued a "Buy" rating on 06/26/2025
• Raymond James issued a "Outperform" rating on 05/09/2025

To track analyst ratings and price targets for AAOI, check out Quiver Quantitative's $AAOI forecast page.

AAOI Price Targets

Multiple analysts have issued price targets for $AAOI recently. We have seen 3 analysts offer price targets for $AAOI in the last 6 months, with a median target of $30.0.

Here are some recent targets:

• Ryan Koontz from Needham set a target price of $32.0 on 07/25/2025
• Mike Genovese from Rosenblatt set a target price of $30.0 on 06/26/2025
• Simon Leopold from Raymond James set a target price of $18.0 on 05/09/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$20,000 of DME CORPORATION (ASTRONICS CORPORATION) lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"radio test equipment"

You can find more data on corporate lobbying on Quiver Quantitative.

ATRO Insider Trading Activity

ATRO insiders have traded $ATRO stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $ATRO stock by insiders over the last 6 months:

• ROBERT S KEANE has made 0 purchases and 4 sales selling 314,799 shares for an estimated $8,293,830.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ATRO Hedge Fund Activity

We have seen 105 institutional investors add shares of ATRO stock to their portfolio, and 79 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BANK OF AMERICA CORP /DE/ added 1,036,860 shares (+2951.6%) to their portfolio in Q1 2025, for an estimated $25,060,906
• EARNEST PARTNERS LLC added 528,491 shares (+inf%) to their portfolio in Q1 2025, for an estimated $12,773,627
• HENNESSY ADVISORS INC added 449,400 shares (+inf%) to their portfolio in Q2 2025, for an estimated $15,045,911
• REDWOOD CAPITAL MANAGEMENT, LLC removed 433,711 shares (-65.8%) from their portfolio in Q1 2025, for an estimated $10,482,794
• PRIVATE CAPITAL MANAGEMENT, LLC added 402,958 shares (+inf%) to their portfolio in Q1 2025, for an estimated $9,739,494
• D. E. SHAW & CO., INC. added 384,067 shares (+188.9%) to their portfolio in Q1 2025, for an estimated $9,282,899
• MILLENNIUM MANAGEMENT LLC added 332,133 shares (+80.1%) to their portfolio in Q1 2025, for an estimated $8,027,654

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ATRO Analyst Ratings

Wall Street analysts have issued reports on $ATRO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Truist Securities issued a "Buy" rating on 07/11/2025

To track analyst ratings and price targets for ATRO, check out Quiver Quantitative's $ATRO forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$10,000 of SENSUS HEALTHCARE INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Coverage and reimbursement for skin cancer treatments"

You can find more data on corporate lobbying on Quiver Quantitative.

SRTS Insider Trading Activity

SRTS insiders have traded $SRTS stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $SRTS stock by insiders over the last 6 months:

• MICHAEL SARDANO (PRESIDENT AND GENERAL COUNSEL) purchased 1,000 shares for an estimated $5,950
• JAVIER RAMPOLLA (CHIEF FINANCIAL OFFICER) purchased 501 shares for an estimated $2,980

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

SRTS Hedge Fund Activity

We have seen 27 institutional investors add shares of SRTS stock to their portfolio, and 43 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 668,880 shares (+inf%) to their portfolio in Q2 2025, for an estimated $3,170,491
• CITADEL ADVISORS LLC removed 197,205 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $932,779
• RENAISSANCE TECHNOLOGIES LLC removed 171,300 shares (-39.8%) from their portfolio in Q1 2025, for an estimated $810,249
• DIMENSIONAL FUND ADVISORS LP added 163,169 shares (+43.1%) to their portfolio in Q1 2025, for an estimated $771,789
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 150,150 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $710,209
• ACADIAN ASSET MANAGEMENT LLC added 122,746 shares (+35.3%) to their portfolio in Q1 2025, for an estimated $580,588
• PACIFIC RIDGE CAPITAL PARTNERS, LLC added 114,500 shares (+inf%) to their portfolio in Q1 2025, for an estimated $541,585

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SRTS Analyst Ratings

Wall Street analysts have issued reports on $SRTS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Maxim Group issued a "Buy" rating on 05/19/2025
• HC Wainwright & Co. issued a "Buy" rating on 04/04/2025
• Lake Street issued a "Buy" rating on 03/11/2025

To track analyst ratings and price targets for SRTS, check out Quiver Quantitative's $SRTS forecast page.

SRTS Price Targets

Multiple analysts have issued price targets for $SRTS recently. We have seen 3 analysts offer price targets for $SRTS in the last 6 months, with a median target of $12.0.

Here are some recent targets:

• Anthony Vendetti from Maxim Group set a target price of $10.0 on 05/19/2025
• Yi Chen from HC Wainwright & Co. set a target price of $12.0 on 04/04/2025
• Ben Haynor from Lake Street set a target price of $13.0 on 03/11/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$40,000 of HONEYWELL INTERNATIONAL INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Department of Defense research and procurement of various types of advanced armor materials, Defense Authorizations and Appropriations Bill inclusion."

You can find more data on corporate lobbying on Quiver Quantitative.

HON Congressional Stock Trading

Members of Congress have traded $HON stock 10 times in the past 6 months. Of those trades, 2 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $HON stock by members of Congress over the last 6 months:

• REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/08.
• REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 04/07.
• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/07.
• REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 04/07.
• SENATOR SHELDON WHITEHOUSE sold up to $50,000 on 04/03.
• REPRESENTATIVE GREG LANDSMAN sold up to $15,000 on 03/27.
• REPRESENTATIVE CAROL D. MILLER purchased up to $15,000 on 03/10.
• SENATOR MARKWAYNE MULLIN sold up to $50,000 on 02/13.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

HON Hedge Fund Activity

We have seen 1,125 institutional investors add shares of HON stock to their portfolio, and 1,282 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO removed 6,697,304 shares (-28.5%) from their portfolio in Q1 2025, for an estimated $1,418,154,122
• BARCLAYS PLC removed 6,061,540 shares (-28.1%) from their portfolio in Q1 2025, for an estimated $1,283,531,095
• ARISTOTLE CAPITAL MANAGEMENT, LLC removed 4,516,642 shares (-99.5%) from their portfolio in Q1 2025, for an estimated $956,398,943
• BLACKROCK, INC. added 2,430,029 shares (+5.4%) to their portfolio in Q1 2025, for an estimated $514,558,640
• CAPITAL WORLD INVESTORS added 2,112,633 shares (+29.9%) to their portfolio in Q1 2025, for an estimated $447,350,037
• 1832 ASSET MANAGEMENT L.P. removed 1,469,092 shares (-83.8%) from their portfolio in Q1 2025, for an estimated $311,080,231
• BANK OF AMERICA CORP /DE/ removed 1,344,340 shares (-9.8%) from their portfolio in Q1 2025, for an estimated $284,663,995

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

HON Analyst Ratings

Wall Street analysts have issued reports on $HON in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Overweight" rating on 07/09/2025
• Citigroup issued a "Buy" rating on 06/04/2025
• Mizuho issued a "Outperform" rating on 05/16/2025
• B of A Securities issued a "Buy" rating on 05/07/2025
• Deutsche Bank issued a "Buy" rating on 02/07/2025

To track analyst ratings and price targets for HON, check out Quiver Quantitative's $HON forecast page.

HON Price Targets

Multiple analysts have issued price targets for $HON recently. We have seen 10 analysts offer price targets for $HON in the last 6 months, with a median target of $250.0.

Here are some recent targets:

• Chris Snyder from Morgan Stanley set a target price of $245.0 on 07/28/2025
• Joseph O'Dea from Wells Fargo set a target price of $230.0 on 07/25/2025
• Deane Dray from RBC Capital set a target price of $253.0 on 07/25/2025
• Julian Mitchell from Barclays set a target price of $265.0 on 07/09/2025
• Andrew Kaplowitz from Citigroup set a target price of $265.0 on 06/04/2025
• Stephen Tusa from JP Morgan set a target price of $217.0 on 05/16/2025
• Brett Linzey from Mizuho set a target price of $250.0 on 05/16/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of QUANTA SERVICES INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Budget Reconciliation: Maintaining tax credits for zero emission electrical generation systems and energy storage property. Energy Permitting Reform: Improving electric transmission siting, permitting, and regulatory practices, and enabling construction of other energy infrastructure. Puerto Rico Electric Grid: Provide updates on efforts to restore and strengthen Puerto Rico's electric transmission and distribution grid."

You can find more data on corporate lobbying on Quiver Quantitative.

PWR Congressional Stock Trading

Members of Congress have traded $PWR stock 6 times in the past 6 months. Of those trades, 2 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $PWR stock by members of Congress over the last 6 months:

• REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $50,000 on 03/31 and 2 sales worth up to $200,000 on 05/12, 02/24.
• REPRESENTATIVE DWIGHT EVANS sold up to $15,000 on 04/03.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 03/14.
• REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 02/25.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

PWR Hedge Fund Activity

We have seen 684 institutional investors add shares of PWR stock to their portfolio, and 600 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• ARTISAN PARTNERS LIMITED PARTNERSHIP removed 2,161,266 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $549,350,591
• KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 1,721,752 shares (+inf%) to their portfolio in Q2 2025, for an estimated $650,959,996
• JPMORGAN CHASE & CO removed 1,125,646 shares (-14.3%) from their portfolio in Q1 2025, for an estimated $286,116,700
• CAPITAL WORLD INVESTORS added 1,100,377 shares (+15.2%) to their portfolio in Q1 2025, for an estimated $279,693,825
• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 952,080 shares (-38.2%) from their portfolio in Q1 2025, for an estimated $241,999,694
• GAMMA INVESTING LLC removed 811,374 shares (-99.5%) from their portfolio in Q2 2025, for an estimated $306,764,281
• AMUNDI added 788,079 shares (+188.3%) to their portfolio in Q1 2025, for an estimated $200,313,920

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PWR Analyst Ratings

Wall Street analysts have issued reports on $PWR in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Stifel issued a "Buy" rating on 08/04/2025
• Roth Capital issued a "Buy" rating on 07/29/2025
• Citigroup issued a "Buy" rating on 07/28/2025
• UBS issued a "Buy" rating on 07/25/2025
• Goldman Sachs issued a "Buy" rating on 06/04/2025
• Piper Sandler issued a "Overweight" rating on 05/27/2025
• Evercore ISI Group issued a "Outperform" rating on 05/02/2025

To track analyst ratings and price targets for PWR, check out Quiver Quantitative's $PWR forecast page.

PWR Price Targets

Multiple analysts have issued price targets for $PWR recently. We have seen 16 analysts offer price targets for $PWR in the last 6 months, with a median target of $393.5.

Here are some recent targets:

• Brian Brophy from Stifel set a target price of $432.0 on 08/04/2025
• Jamie Cook from Truist Securities set a target price of $472.0 on 08/04/2025
• Brent Thielman from DA Davidson set a target price of $395.0 on 08/01/2025
• Philip Shen from Roth Capital set a target price of $450.0 on 07/29/2025
• Andrew Kaplowitz from Citigroup set a target price of $492.0 on 07/28/2025
• Steven Fisher from UBS set a target price of $474.0 on 07/25/2025
• Drew Chamberlain from JP Morgan set a target price of $392.0 on 07/22/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$480,000 of NATIONAL FUEL GAS COMPANY lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"LIHEAP, pipeline permitting reform, climate change policy, pipeline safety reauthorization, energy policy (including renewable natural gas and hydrogen), natural gas appliances , federal oversight of natural gas use, Energy Star program, pipeline security & cybersecurity, natural gas use in federal facilities -- U.S. House of Representatives, U.S. Senate"

You can find more data on corporate lobbying on Quiver Quantitative.

NFG Hedge Fund Activity

We have seen 282 institutional investors add shares of NFG stock to their portfolio, and 246 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• THOMPSON SIEGEL & WALMSLEY LLC removed 720,855 shares (-70.7%) from their portfolio in Q1 2025, for an estimated $57,084,507
• VICTORY CAPITAL MANAGEMENT INC removed 581,143 shares (-22.5%) from their portfolio in Q1 2025, for an estimated $46,020,714
• GEODE CAPITAL MANAGEMENT, LLC removed 510,802 shares (-23.2%) from their portfolio in Q1 2025, for an estimated $40,450,410
• LSV ASSET MANAGEMENT added 491,890 shares (+29.6%) to their portfolio in Q1 2025, for an estimated $38,952,769
• INVESCO LTD. added 460,100 shares (+93.7%) to their portfolio in Q1 2025, for an estimated $36,435,319
• VANGUARD GROUP INC removed 427,159 shares (-3.3%) from their portfolio in Q1 2025, for an estimated $33,826,721
• MACKENZIE FINANCIAL CORP added 355,800 shares (+98.9%) to their portfolio in Q1 2025, for an estimated $28,175,802

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NFG Analyst Ratings

Wall Street analysts have issued reports on $NFG in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• B of A Securities issued a "Buy" rating on 07/15/2025
• Scotiabank issued a "Sector Outperform" rating on 07/11/2025

To track analyst ratings and price targets for NFG, check out Quiver Quantitative's $NFG forecast page.

NFG Price Targets

Multiple analysts have issued price targets for $NFG recently. We have seen 5 analysts offer price targets for $NFG in the last 6 months, with a median target of $85.0.

Here are some recent targets:

• Noah Hungness from B of A Securities set a target price of $107.0 on 07/15/2025
• Cameron Bean from Scotiabank set a target price of $98.0 on 07/11/2025
• Zach Parham from JP Morgan set a target price of $81.0 on 03/13/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of NMI HOLDINGS INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"*No specific bill number/all matters relating to housing and PMI Insurance"

You can find more data on corporate lobbying on Quiver Quantitative.

NMIH Insider Trading Activity

NMIH insiders have traded $NMIH stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.

Here’s a breakdown of recent trading of $NMIH stock by insiders over the last 6 months:

• ADAM POLLITZER (Chief Executive Officer) sold 57,166 shares for an estimated $2,089,051
• WILLIAM J LEATHERBERRY (Chief Admin. Officer & GC) has made 0 purchases and 3 sales selling 42,121 shares for an estimated $1,584,040.
• BRADLEY M SHUSTER (Executive Chairman) sold 21,545 shares for an estimated $852,283
• ROBERT OWEN SMITH (EVP, Chief Risk Officer) sold 20,000 shares for an estimated $731,581
• NORMAN PETER FITZGERALD (EVP, Chief Sales Officer) sold 20,000 shares for an estimated $717,600
• MOHAMMAD NAWAZ YOUSAF (EVP, Chief of Ops and Tech) has made 0 purchases and 2 sales selling 16,600 shares for an estimated $591,717.
• NICHOLAS DANIEL REALMUTO (VP, Controller) has made 0 purchases and 5 sales selling 5,599 shares for an estimated $97,334.
• MICHAEL CURRY MONTGOMERY sold 1,875 shares for an estimated $71,344

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NMIH Hedge Fund Activity

We have seen 168 institutional investors add shares of NMIH stock to their portfolio, and 156 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC removed 1,174,358 shares (-81.3%) from their portfolio in Q1 2025, for an estimated $42,335,605
• ASSENAGON ASSET MANAGEMENT S.A. removed 1,002,191 shares (-49.3%) from their portfolio in Q2 2025, for an estimated $42,282,438
• MILLENNIUM MANAGEMENT LLC added 970,551 shares (+209.9%) to their portfolio in Q1 2025, for an estimated $34,988,363
• BLACKROCK, INC. removed 605,089 shares (-4.4%) from their portfolio in Q1 2025, for an estimated $21,813,458
• GOLDENTREE ASSET MANAGEMENT LP added 512,527 shares (+61.5%) to their portfolio in Q1 2025, for an estimated $18,476,598
• DONALD SMITH & CO., INC. removed 459,234 shares (-35.1%) from their portfolio in Q1 2025, for an estimated $16,555,385
• INVESCO LTD. removed 362,652 shares (-38.8%) from their portfolio in Q1 2025, for an estimated $13,073,604

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NMIH Analyst Ratings

Wall Street analysts have issued reports on $NMIH in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• JP Morgan issued a "Overweight" rating on 07/11/2025
• Compass Point issued a "Buy" rating on 05/23/2025
• Keefe, Bruyette & Woods issued a "Outperform" rating on 04/08/2025

To track analyst ratings and price targets for NMIH, check out Quiver Quantitative's $NMIH forecast page.

NMIH Price Targets

Multiple analysts have issued price targets for $NMIH recently. We have seen 5 analysts offer price targets for $NMIH in the last 6 months, with a median target of $42.0.

Here are some recent targets:

• Richard Shane from JP Morgan set a target price of $44.0 on 07/11/2025
• Terry Ma from Barclays set a target price of $42.0 on 07/08/2025
• Bose George from Keefe, Bruyette & Woods set a target price of $43.0 on 07/07/2025
• Chris Gamaitoni from Compass Point set a target price of $37.0 on 05/23/2025
• Doug Harter from UBS set a target price of $41.0 on 02/19/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$150,000 of CORMEDIX INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R.____/S.____, Chronic Kidney Disease Improvement in Research and Treatment Act Issues related to patient access to infection prevention."

You can find more data on corporate lobbying on Quiver Quantitative.

CRMD Hedge Fund Activity

We have seen 77 institutional investors add shares of CRMD stock to their portfolio, and 51 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FIRST TURN MANAGEMENT, LLC removed 1,021,421 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $6,291,953
• OBERWEIS ASSET MANAGEMENT INC/ added 485,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,987,600
• J. GOLDMAN & CO LP removed 457,320 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,817,091
• ELLIOTT INVESTMENT MANAGEMENT L.P. removed 426,071 shares (-14.8%) from their portfolio in Q1 2025, for an estimated $2,624,597
• MORGAN STANLEY added 304,891 shares (+76.4%) to their portfolio in Q1 2025, for an estimated $1,878,128
• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 295,623 shares (+1106.1%) to their portfolio in Q1 2025, for an estimated $1,821,037
• VANGUARD GROUP INC added 268,360 shares (+7.9%) to their portfolio in Q1 2025, for an estimated $1,653,097

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CRMD Analyst Ratings

Wall Street analysts have issued reports on $CRMD in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• HC Wainwright & Co. issued a "Buy" rating on 06/30/2025
• Needham issued a "Buy" rating on 06/24/2025
• RBC Capital issued a "Outperform" rating on 06/20/2025
• Leerink Partners issued a "Outperform" rating on 03/07/2025

To track analyst ratings and price targets for CRMD, check out Quiver Quantitative's $CRMD forecast page.

CRMD Price Targets

Multiple analysts have issued price targets for $CRMD recently. We have seen 6 analysts offer price targets for $CRMD in the last 6 months, with a median target of $17.5.

Here are some recent targets:

• Brandon Folkes from HC Wainwright & Co. set a target price of $20.0 on 06/30/2025
• Serge Belanger from Needham set a target price of $20.0 on 06/24/2025
• Jason Kolbert from D. Boral Capital set a target price of $15.0 on 06/23/2025
• Leonid Timashev from RBC Capital set a target price of $17.0 on 06/20/2025
• Roanna Ruiz from Leerink Partners set a target price of $18.0 on 03/07/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$200,000 of WOODSIDE ENERGY GROUP LTD lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Discussed international trade policy impact on building a domestic LNG project and on US LNG exports to foreign nations. Update on Woodside Energy's LNG export facility, Louisiana LNG, and progress being made towards project completion. Issues related to offshore oil & gas lease sales and regulations. Discussed tariffs impact on materials needed to build a domestic LNG project and on US LNG exports to foreign nations."

You can find more data on corporate lobbying on Quiver Quantitative.

WDS Hedge Fund Activity

We have seen 114 institutional investors add shares of WDS stock to their portfolio, and 129 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC removed 1,426,683 shares (-77.6%) from their portfolio in Q1 2025, for an estimated $20,672,636
• POINT72 ASSET MANAGEMENT, L.P. added 729,400 shares (+inf%) to their portfolio in Q1 2025, for an estimated $10,569,006
• GOLDMAN SACHS GROUP INC removed 597,212 shares (-19.9%) from their portfolio in Q1 2025, for an estimated $8,653,601
• VOLORIDGE INVESTMENT MANAGEMENT, LLC added 519,231 shares (+150.3%) to their portfolio in Q1 2025, for an estimated $7,523,657
• MARSHALL WACE, LLP removed 477,935 shares (-95.5%) from their portfolio in Q1 2025, for an estimated $6,925,278
• ASSOCIATED BANC-CORP removed 429,768 shares (-72.2%) from their portfolio in Q1 2025, for an estimated $6,227,338
• UBS GROUP AG removed 370,166 shares (-78.4%) from their portfolio in Q1 2025, for an estimated $5,363,705

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$50,000 of VAXART INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Vaccine policy."

You can find more data on corporate lobbying on Quiver Quantitative.

VXRT Insider Trading Activity

VXRT insiders have traded $VXRT stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $VXRT stock by insiders over the last 6 months:

• STEVEN LO (President, Chief Exec Officer) purchased 100,000 shares for an estimated $49,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

VXRT Hedge Fund Activity

We have seen 26 institutional investors add shares of VXRT stock to their portfolio, and 35 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• SIO CAPITAL MANAGEMENT, LLC removed 5,931,867 shares (-51.5%) from their portfolio in Q1 2025, for an estimated $2,414,269
• MILLENNIUM MANAGEMENT LLC removed 2,034,776 shares (-68.0%) from their portfolio in Q1 2025, for an estimated $828,153
• CITADEL ADVISORS LLC removed 501,623 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $204,160
• JONES FINANCIAL COMPANIES LLLP added 478,111 shares (+276364.7%) to their portfolio in Q1 2025, for an estimated $194,591
• SILVERARC CAPITAL MANAGEMENT, LLC removed 393,957 shares (-36.6%) from their portfolio in Q1 2025, for an estimated $160,340
• VANGUARD GROUP INC added 291,506 shares (+2.9%) to their portfolio in Q1 2025, for an estimated $118,642
• SQUAREPOINT OPS LLC added 287,677 shares (+55.7%) to their portfolio in Q1 2025, for an estimated $117,084

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

VXRT Analyst Ratings

Wall Street analysts have issued reports on $VXRT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• B. Riley Securities issued a "Buy" rating on 03/27/2025

To track analyst ratings and price targets for VXRT, check out Quiver Quantitative's $VXRT forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$10,000 of DIEBOLD NIXDORF lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R.1138 - Payment Choice Act of 2025 This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less, and it prohibits them from charging cash- paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill provides for enforcement through preventative relief, damages, and civil penalties. H.R.1138 - Payment Choice Act of 2025 This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less, and it prohibits them from charging cash- paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill provides for enforcement through preventative relief, damages, and civil penalties. H.R.1138 - Payment Choice Act of 2025 This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less, and it prohibits them from charging cash- paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill provides for enforcement through preventative relief, damages, and civil penalties."

You can find more data on corporate lobbying on Quiver Quantitative.

DBD Insider Trading Activity

DBD insiders have traded $DBD stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $DBD stock by insiders over the last 6 months:

• WORLD INVESTORS CAPITAL sold 19,842 shares for an estimated $866,103
• EMANUEL R PEARLMAN has made 0 purchases and 2 sales selling 2,000 shares for an estimated $87,360.
• FRANK TOBIAS BAUR (EVP of Operational Excellence) purchased 700 shares for an estimated $32,284

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DBD Hedge Fund Activity

We have seen 61 institutional investors add shares of DBD stock to their portfolio, and 65 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BEACH POINT CAPITAL MANAGEMENT LP removed 317,399 shares (-16.8%) from their portfolio in Q2 2025, for an estimated $17,583,904
• NEW VERNON CAPITAL HOLDINGS II LLC added 244,351 shares (+inf%) to their portfolio in Q1 2025, for an estimated $10,683,025
• GLENDON CAPITAL MANAGEMENT LP added 180,232 shares (+13.7%) to their portfolio in Q1 2025, for an estimated $7,879,743
• UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH added 153,600 shares (+inf%) to their portfolio in Q1 2025, for an estimated $6,715,392
• WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 140,290 shares (+9.5%) to their portfolio in Q2 2025, for an estimated $7,772,066
• DIMENSIONAL FUND ADVISORS LP added 114,486 shares (+18.2%) to their portfolio in Q1 2025, for an estimated $5,005,327
• SKYLANDS CAPITAL, LLC added 103,975 shares (+23.3%) to their portfolio in Q1 2025, for an estimated $4,545,787

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

DBD Analyst Ratings

Wall Street analysts have issued reports on $DBD in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• DA Davidson issued a "Buy" rating on 02/27/2025

To track analyst ratings and price targets for DBD, check out Quiver Quantitative's $DBD forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$340,000 of KLA CORPORATION lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Research and development funding and tax benefits in support of the semiconductor industry. Trade policy regarding China, including tariffs and export controls on semiconductor manufacturing equipment for advanced models."

You can find more data on corporate lobbying on Quiver Quantitative.

KLAC Insider Trading Activity

KLAC insiders have traded $KLAC stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $KLAC stock by insiders over the last 6 months:

• RICHARD P WALLACE (President and CEO) sold 10,802 shares for an estimated $7,381,006
• BREN D. HIGGINS (EVP & Chief Financial Officer) has made 0 purchases and 2 sales selling 8,027 shares for an estimated $5,859,159.
• VIRENDRA A KIRLOSKAR (SVP & Chief Accounting Officer) sold 39 shares for an estimated $34,768

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

KLAC Hedge Fund Activity

We have seen 751 institutional investors add shares of KLAC stock to their portfolio, and 724 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GAMMA INVESTING LLC removed 1,671,582 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $1,497,302,860
• CAPITAL WORLD INVESTORS added 675,430 shares (+inf%) to their portfolio in Q1 2025, for an estimated $459,157,313
• GOLDMAN SACHS GROUP INC added 404,634 shares (+27.9%) to their portfolio in Q1 2025, for an estimated $275,070,193
• QUBE RESEARCH & TECHNOLOGIES LTD removed 383,182 shares (-87.6%) from their portfolio in Q1 2025, for an estimated $260,487,123
• MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 350,072 shares (-17.1%) from their portfolio in Q1 2025, for an estimated $237,978,945
• PROFICIO CAPITAL PARTNERS LLC removed 341,905 shares (-99.8%) from their portfolio in Q1 2025, for an estimated $232,427,018
• PRIMECAP MANAGEMENT CO/CA/ removed 307,560 shares (-5.9%) from their portfolio in Q1 2025, for an estimated $209,079,288

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

KLAC Analyst Ratings

Wall Street analysts have issued reports on $KLAC in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Morgan Stanley issued a "Overweight" rating on 07/01/2025
• Oppenheimer issued a "Outperform" rating on 06/17/2025
• Needham issued a "Buy" rating on 05/01/2025
• Stifel issued a "Buy" rating on 05/01/2025
• JP Morgan issued a "Overweight" rating on 05/01/2025
• B of A Securities issued a "Buy" rating on 04/16/2025
• Citigroup issued a "Buy" rating on 04/11/2025

To track analyst ratings and price targets for KLAC, check out Quiver Quantitative's $KLAC forecast page.

KLAC Price Targets

Multiple analysts have issued price targets for $KLAC recently. We have seen 15 analysts offer price targets for $KLAC in the last 6 months, with a median target of $900.0.

Here are some recent targets:

• Tom O'Malley from Barclays set a target price of $750.0 on 07/28/2025
• Timothy Arcuri from UBS set a target price of $960.0 on 07/21/2025
• James Schneider from Goldman Sachs set a target price of $980.0 on 07/10/2025
• Joseph Quatrochi from Wells Fargo set a target price of $920.0 on 07/08/2025
• Atif Malik from Citigroup set a target price of $1035.0 on 07/07/2025
• Shane Brett from Morgan Stanley set a target price of $916.0 on 07/01/2025
• Matthew Prisco from Cantor Fitzgerald set a target price of $950.0 on 06/24/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$180,000 of SHOPIFY INC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to the reform of laws relating to the protection of intellectual property rights. Issues related to competition in the market for credit card routing, including support for The Credit Card Competition Act. Issues related to the growth of independent small businesses in the digital economy. Issues related to online government resources for small businesses, including support for the One Stop Shop for Small Business Licensing Act. Issues related to modernizing small business grants and mentoring to promote a greater focus on e-commerce. Issues related to combating online sale of counterfeit goods. Issues related to consumer privacy. Issues related to Self-Employment Assistance programs and removing barriers to entrepreneurship in unemployment insurance, including support for The NO BOSS Act. Issues related to accessibility standards for website design. Issues related to artificial intelligence and its benefits for small business. Issues related to the regulation of financial technology. Issues related to small business and corporate tax reform, including support for H.R. 703 / S. 213, the Main Street Tax Certainty Act, and H.R. 1, One Big Beautiful Bill Act. Issues related to the impact of tariffs and changes to the de minimis exemption on small businesses."

You can find more data on corporate lobbying on Quiver Quantitative.

SHOP Congressional Stock Trading

Members of Congress have traded $SHOP stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $SHOP stock by members of Congress over the last 6 months:

• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/03.
• REPRESENTATIVE JOSH GOTTHEIMER has traded it 3 times. They made 2 purchases worth up to $30,000 on 02/12, 02/03 and 1 sale worth up to $15,000 on 03/19.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

SHOP Hedge Fund Activity

We have seen 706 institutional investors add shares of SHOP stock to their portfolio, and 686 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• EDGEWOOD MANAGEMENT LLC added 8,646,159 shares (+inf%) to their portfolio in Q1 2025, for an estimated $825,535,261
• PRICE T ROWE ASSOCIATES INC /MD/ removed 7,892,382 shares (-18.8%) from their portfolio in Q1 2025, for an estimated $753,564,633
• FMR LLC added 5,507,642 shares (+12.6%) to their portfolio in Q1 2025, for an estimated $525,869,658
• JPMORGAN CHASE & CO added 4,597,678 shares (+19.6%) to their portfolio in Q1 2025, for an estimated $438,986,295
• GOLDMAN SACHS GROUP INC added 4,550,721 shares (+128.0%) to their portfolio in Q1 2025, for an estimated $434,502,841
• JENNISON ASSOCIATES LLC added 4,036,326 shares (+324.3%) to their portfolio in Q1 2025, for an estimated $385,388,406
• BAILLIE GIFFORD & CO removed 3,898,764 shares (-6.5%) from their portfolio in Q1 2025, for an estimated $372,253,986

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SHOP Analyst Ratings

Wall Street analysts have issued reports on $SHOP in the last several months. We have seen 16 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Oppenheimer issued a "Outperform" rating on 07/28/2025
• CIBC issued a "Outperformer" rating on 07/18/2025
• Baird issued a "Outperform" rating on 07/14/2025
• Needham issued a "Buy" rating on 07/14/2025
• DA Davidson issued a "Buy" rating on 06/16/2025
• Wells Fargo issued a "Overweight" rating on 06/06/2025
• JP Morgan issued a "Overweight" rating on 05/09/2025

To track analyst ratings and price targets for SHOP, check out Quiver Quantitative's $SHOP forecast page.

SHOP Price Targets

Multiple analysts have issued price targets for $SHOP recently. We have seen 29 analysts offer price targets for $SHOP in the last 6 months, with a median target of $120.0.

Here are some recent targets:

• Ken Wong from Oppenheimer set a target price of $145.0 on 07/28/2025
• Justin Patterson from Keybanc set a target price of $145.0 on 07/22/2025
• Anthony Chukumba from Loop Capital set a target price of $120.0 on 07/22/2025
• Todd Coupland from CIBC set a target price of $145.0 on 07/18/2025
• Parker Lane from Stifel set a target price of $110.0 on 07/15/2025
• Scott Berg from Needham set a target price of $135.0 on 07/14/2025
• Colin Sebastian from Baird set a target price of $120.0 on 07/14/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.